UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 10-Q

 

[x]       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the quarterly period ended September 30, 2016

 

OR

 

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the transition period from ___________to ____________

 

Commission File Number 333-197821

 

SQL TECHNOLOGIES CORP.

(Exact name of small business issuer as specified in its charter)

 

FLORIDA 46-3645414

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

4400 North Point Parkway

Suite 154

Alpharetta, GA 30022

(Address, including zip code, of principal executive offices)

 

(770) 754-4711

(Issuer’s telephone number)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every

Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerate filer [ ] Accelerated Filer [ ]

Non-accelerated filer [ ] Smaller reporting company [x]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes [ ] No [x]

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of November 14, 2016, the issuer had 47,276,499 shares of common stock issued and outstanding.

 

 

 

 
 

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION 1
Item 1. Consolidated Financial Statements 1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 29
Item 3. Quantitative & Qualitative Disclosures about Market Risks 41
Item 4. Controls and Procedures 41
PART II OTHER INFORMATION 42
Item 1. Legal Proceedings 42
Item 1A. Risk Factors 4 2
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42
Item 3. Defaults upon Senior Securities 43
Item 5. Other Information 43
Item 6. Exhibits 44

 

Unless we have indicated otherwise or the context otherwise requires, references in this Quarter Report on Form 10-Q to the “Company”, “we”, “us”, and “our” or similar terms are to “SQL Technologies Corp.”

 

 
 

PART I. FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

SQL Technologies Corp. and Subsidiary

Consolidated Balance Sheets

 
    (Unaudited)   (Audited)
    September 30, 2016   December 31, 2015
Assets                
                 
Current assets:                
Cash   $ 4,997,643     $ 450,868  
Accounts receivable     1,669,322       234,309  
Inventory     2,969,766       263,871  
Prepaid expenses     21,435       35,769  
Other current assets     78,000       210  
Total current assets     9,736,166       985,028  
                 
Furniture and Equipment - net     118,645       127,521  
                 
Other assets:                
Patent - net     100,276       83,174  
Debt issue costs - net     —         14,605  
GE trademark license - net     5,290,970       7,123,746  
Other assets     124,765       65,714  
Total other assets     5,516,011       7,287,239  
                 
Total assets   $ 15,370,822     $ 8,399,788  
                 
                 
Liabilities and Stockholders (Deficit)                
                 
Current liabilities:                
Accounts payable & accrued expenses   $ 2,377,140     $ 807,798  
Convertible debt - net of debt discount  $-0- and $474,283 at     1,694,233       3,989,950  
September 30, 2016 and December 31, 2015 respectively                
Convertible debt - related parties - net of debt discount  $-0- and     50,000       50,000  
$-0- at September 30, 2016 and December 31, 2015 respectively                
Notes payable - current portion     3,118,018       107,944  
Notes payable - related party     200,000       —    
Derivative liabilities     25,016,860       24,157,838  
Other current liabilities     7,180       46,010  
Total current liabilities     32,463,431       29,159,540  
                 
Long term liabilities:                
Notes payable     104,276       193,800  
GE royalty obligation     11,409,934       11,795,855  
Total long term liabilities     11,514,210       11,989,655  
                 
Total liabilities     43,977,641       41,149,195  
                 

 

Table Of Contents  

1

 
 

Stockholders' deficit:          
Preferred stock: $0 par value, 20,000,000 shares authorized;           
7,080,000 and -0- shares issued and outstanding          
at September 30, 2016 and December 31, 2015 respectively                            24,072,000                                             -       
Common stock: $0 par value, 500,000,000 shares authorized;           
47,076,499 and 41,501,251 shares issued and outstanding          
at September 30, 2016 and December 31, 2015 respectively                            11,506,641                              2,892,078    
Common stock to be issued                                              -                                    625,000    
Additional paid-in capital                            51,487,789                              6,472,427    
Accumulated deficit                        (116,393,807)                          (42,703,470)    
Total Stockholders' deficit                           (28,571,377)                          (32,713,965)    
Non-controlling interest                                   (35,442)                                  (35,442)    
Total Deficit                           (28,606,819)                          (32,749,407)    
           
Total liabilities and stockholders' deficit  $                        15,370,822    $                        8,399,788    

 

        The accompanying notes are an integral part of these condensed consolidated financial statements.  

Table Of Contents  

2

 
 

SQL Technologies Corp. and Subsidiary

Consolidated Statements of Operations

Nine Months Ended September 30, 2016 and 2015

(Unaudited)

 

  Three Months   Nine Months
  September 30, 2016   September 30, 2015   September 30, 2016   September 30, 2015
               
Sales  $                    1,932,312    $                       262,897    $                    5,534,741    $                    2,482,035
               
Cost of sales                      (1,593,926)                            (248,675)                        (4,848,476)                        (2,195,655)
               
Gross profit                           338,386                                14,222                             686,265                             286,380
               
General and administrative expenses                        1,613,880                          1,220,844                          4,550,323                          3,741,198
               
Loss from operations                      (1,275,494)                        (1,206,622)                        (3,864,058)                        (3,454,818)
               
Other income (expense)              
Interest expense                          (139,924)                            (880,394)                            (902,690)                        (2,273,951)
Derivative expenses                      (2,446,918)                                           -                        (7,410,369)                                           -
Change in fair value of embedded derivative liabilities                      (3,183,183)                        (7,993,408)                      (38,644,799)                        (7,357,719)
Loss on debt extinguishment - net                    (22,121,217)                                           -                      (22,121,217)                                           -
Other income                                4,648                                           -                                  8,796                                           -
Total other expense - net                    (27,886,594)                        (8,873,802)                      (69,070,279)                        (9,631,670)
               
Net income (loss) including non-controlling interest                    (29,162,088)                      (10,080,424)                      (72,934,337)                      (13,086,489)
Less: net loss attributable to non-controlling interest                                         -                                           -                                           -                                           -
Net income (loss) attributable to SQL Technologies Corp.  $                (29,162,088)    $                (10,080,424)    $                (72,934,337)    $                (13,086,489)
               
Net loss per share - basic and diluted  $                            (0.624)    $                            (0.25)    $                            (1.634)    $                            (0.34)
               
Weighted average number of common shares outstanding during the year -               
basic and diluted                      46,702,330                        40,479,962                        44,830,045                        38,131,295

 

        The accompanying notes are an integral part of these condensed consolidated financial statements.

Table Of Contents  

3

 
 

 

SQL Technologies Corp. and Subsidiary

Consolidated Statements of Cash Flows

Nine Months Ended September 30, 2016 and 2015

(Unaudited)

 

  Nine Months
  September 30, 2016   September 30, 2015
Cash flows from operating activities:      
Net loss attributable to SQL Technologies Corp.  $                      (72,934,337)    $                      (13,086,489)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense                                    19,714                                      16,471
Amortization of debt issue costs                                    14,605                                    117,098
Amortization of debt discount                                  474,283                                1,621,257
Amortization of patent                                       5,774                                        3,705
Amortization of GE trademark license                              1,832,777                                1,826,087
Change in fair value of derivative liabilities                            38,644,799                                7,357,719
Derivative expense                              7,410,369                                               -   
Gain on debt extinguishment                                (180,783)                                               -   
Loss on debt extinguishment                            22,302,000                                               -   
Stock options issued for services - related parties                                  193,250                                      62,500
Change in operating assets and liabilities:      
Accounts receivable                          (1,435,013)                               (116,878)
Prepaid expenses                                 14,334                                   11,583
Inventory                          (2,705,895)                               (514,186)
Royalty payable                             (385,922)                               (178,043)
Other                             (175,671)                                 (22,999)
Accounts payable & accrued expenses                           1,569,345                                   36,239
Net cash used in operating activities                             (5,336,371)                               (2,865,936)
       
Cash flows from investing activities:      
Purchase of property & equipment                                  (10,837)                                       (3,053)
Payment of patent costs                                  (22,877)                                    (28,302)
Net cash used in investing activities                                  (33,714)                                    (31,355)
       
Cash flows from financing activities:      
Repayments of convertible notes                             (2,770,000)                                               -   
Proceeds from note payable                              3,791,576                                               -   
Proceeds from note payable - related party                                  500,000                                               -   
Stock issued in exchange for interest                                  158,312                                    429,646
Stock issued in exchange for principal                              1,870,000                                               -   
Repayments of notes                                (871,028)                                    (77,201)
Repayments of notes - related party                                (300,000)                                               -   
Proceeds from issuance of stock                              7,538,000                                1,970,832
Net cash provided by financing activities                              9,916,860                                2,323,277
       
(Decrease) Increase cash and cash equivalents                              4,546,775                                  (574,014)
Cash and cash equivalents at beginning of period                                  450,868                                1,241,487
Cash and cash equivalents at end of period  $                          4,997,643    $                             667,473
       

 

Table Of Contents  

4

 
 

Supplementary disclosure of non-cash financing activities:      
Reduction in principal balance of notes from escrow balance  $                                          -    $                                           -
Debt discount recorded on convertible debt accounted for as a derivative liability $                                          -    $                                           -
Reclassification of derivative liability to additional paid-in-capital $                       45,015,362    $                                           -
       
       
Supplementary disclosure of cash flow information      
Cash paid during the period for:      
Interest  $                                75,887    $                             457,297

 

                   The accompanying notes are an integral part of these condensed consolidated financial statements.

Table Of Contents  

5

 
 

SQL Technologies Corp. and Subsidiary

Notes to Condensed Financial Statements

 

Note 1 Organization and Nature of Operations

 

SQL Technologies Corp. (f/k/a Safety Quick Lighting & Fans Corp.), a Florida corporation (the “Company”), was originally organized in May 2004 as a limited liability company under the name of Safety Quick Light, LLC. The Company was converted to corporation on November 6, 2012. Effective August 12, 2016, the Company changed its name from “Safety Quick Lighting & Fans Corp.” to “SQL Technologies Corp.” The Company holds a number of worldwide patents, and has received a variety of final electrical code approvals, including UL Listing and CSA approval (for the United States and Canadian Markets), and CE (for the European market). The Company maintains offices in Georgia, Florida and in Foshan, Peoples Republic of China.

 

The Company is engaged in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans, by the use of a power plug installed in ceiling and wall electrical junction boxes. The Company’s main technology consists of a weight bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior.

 

The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post and is capable of feeding electric power to an appliance. The plug includes a second structural element allowing it to revolve and a releasable latching which, when engaged, provides a retention force between the socket and the plug to prevent disengagement. The socket and plug can be detached by releasing the latch, thereby disengaging the electric power from the plug. The socket is designed to replace the support bar incorporated in electric junction boxes, and the plug can be installed in light fixtures, ceiling fans and wall sconce fixtures.

 

The Company markets consumer friendly, energy saving “plugin” ceiling fans and light fixtures under the General Electric Company (“GE” or “General Electric”) brand as well as “conventional” ceiling lights and fans carrying the GE brand. The Company also owns 98.8% of SQL Lighting & Fans LLC (the “Subsidiary”). The Subsidiary was formed in Florida on April 27, 2011, and is in the business of manufacturing the patented device that the Company owns. The Subsidiary had no activity during the periods presented.

 

The Company’s fiscal year end is December 31.

 

Note 2 Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) under the accrual basis of accounting.

 

Table Of Contents  

6

 
 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.

 

Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.

 

Risks and Uncertainties

 

The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure.

 

The Company has experienced, and in the future expects to continue to experience, variability in its sales and earnings. The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at large national retail chains where product is expected to be sold (iii) general economic conditions and (iv) the related volatility of prices pertaining to the cost of sales.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of SQL Technologies Corp. (f/k/a Safety Quick Lighting and Fans Corp.) and the Subsidiary, SQL Lighting & Fans LLC. All intercompany accounts and transactions have been eliminated in consolidation.

 

Non-controlling Interest

 

In May 2012, in connection with the sale of the Company’s membership units in the Subsidiary, the Company’s ownership percentage in the Subsidiary decreased from 98.8% to 94.35%. The Company then reacquired these membership units in September 2013, increasing the ownership percentage from 94.35% back to 98.8%. During 2014, there was no activity in the Subsidiary. Its pro rata share of the Company’s 2014 and 2015 loss from operations is recognized in the financial statements.

 

Cash and Cash Equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions, and all highly liquid investments with an original maturity of three months or less. The Company had $4,997,643 and $450,868 in money market as of September 30, 2016 and December 31, 2015, respectively.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company extends unsecured credit to its customers in the ordinary course of business but mitigates the associated risks by performing credit checks and actively pursuing past due accounts.

 

Table Of Contents  

7

 
 

The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future bad debts, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible.

 

The Company’s net balance of accounts receivable for three months ended September 30, 2016 and for the year ended December 31, 2015:

 

   

September 30, 2016

(Unaudited)

 

December 31, 2015

(Audited)

                 
 Accounts Receivable   $ 1,669,322     $      234,309  
 Allowance for Doubtful Accounts            
 Net Accounts Receivable   $ 1,669,322     $      234,309  

 

All amounts are deemed collectible at September 30, 2016 and December 31, 2015 and accordingly, the Company has not incurred any bad debt expense at September 30, 2016 and December 31, 2015.

 

Inventory

 

Inventory consists of finished goods purchased, which are valued at the lower of cost or market value, with cost being determined on the first-in, first-out (FIFO) method. The Company periodically reviews historical sales activity to determine potentially obsolete items and also evaluates the impact of any anticipated changes in future demand.

 

At September 30, 2016 and December 31, 2015, the Company had $2,969,766 and $263,871 in inventory, respectively. The Company will maintain an allowance based on specific inventory items that have shown no activity over a 24-month period. The Company tracks inventory as it is disposed, scrapped or sold at below cost to determine whether additional items on hand should be reduced in value through an allowance method. As of September 30, 2016, and December 31, 2015, the Company has determined that no allowance is required.

 

Valuation of Long-lived Assets and Identifiable Intangible Assets

 

The Company reviews for impairment of long-lived assets and certain identifiable intangible assets whenever events or changes in circumstances indicate that the carrying amount of any asset may not be recoverable. In the event of impairment, the asset is written down to its fair market value. The Company determined no impairment adjustment was necessary for the periods presented.

 

Property and Equipment

 

Property and equipment is stated at cost, less accumulated depreciation, and is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5 to 7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred.

 

Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

 

Table Of Contents  

8

 
 

Intangible Asset Patent

 

The Company developed a patent for an installation device used in light fixtures and ceiling fans. Costs incurred for submitting the applications to the United States Patent and Trademark Office for these patents have been capitalized. Patent costs are being amortized using the straight-line method over the related 15 year lives. The Company begins amortizing patent costs once a filing receipt is received stating the patent serial number and filing date from the Patent Office.

 

The Company incurs certain legal and related costs in connection with patent applications. The Company capitalizes such costs to be amortized over the expected life of the patent to the extent that an economic benefit is anticipated from the resulting patent or alternative future use is available to the Company. The Company also capitalizes legal costs incurred in the defense of the Company’s patents when it is believed that the future economic benefit of the patent will be maintained or increased and a successful defense is probable. Capitalized patent defense costs are amortized over the remaining expected life of the related patent. The Company’s assessment of future economic benefit or a successful defense of its patents involves considerable management judgment, and an unfavorable outcome of litigation could result in a material impairment charge up to the carrying value of these assets.

 

GE Trademark Licensing Agreement

 

The Company entered into a Trademark License Agreement with General Electric on September, 2011 (the “License Agreement”) allowing the Company to utilize the “GE trademark” on products which meet the stringent manufacturing and quality requirements of General Electric (the “GE Trademark License”). As described further in Note 5 to these financial statements, the Company and General Electric amended the License Agreement in August 2014. As a result of that amendment, the Company is required to pay a minimum trademark licensing fee (the “Royalty Obligation”) to General Electric of $12,000,000. The repayment schedule is based on a percent of sales, with any unpaid balance due in November 2018. Under SFAS 142 “Accounting for Certain Intangible Assets” the Company has recorded the value of the Licensing Agreement and will amortize it over the life of the License Agreement, which is 60 months.

   

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
Level 2 Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

Table Of Contents  

9

 
 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable – related party, approximate their fair values because of the short maturity of these instruments.

 

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under Level 3. See Note 9.

 

Embedded Conversion Features

 

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 47020 “Debt with Conversion and Other Options” for consideration of any beneficial conversion features.

 

Derivative Financial Instruments

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting date, with changes in the fair value reported as charges or credits to income.

 

For option based simple derivative financial instruments, the Company uses the Black Scholes option pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period.

 

Beneficial Conversion Feature

 

For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount.

 

When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid in capital) and amortized to interest expense over the life of the debt.

 

Debt Issue Costs and Debt Discount

 

The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

 

Original Issue Discount

 

For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.

 

Extinguishments of Liabilities

 

The Company accounts for extinguishments of liabilities in accordance with ASC 86010 (formerly SFAS 140) “Accounting for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities”. When the conditions are met for extinguishment accounting, the liabilities are derecognized and the gain or loss on the sale is recognized.

 

Table Of Contents  

10

 
 

Stock Based Compensation – Employees

 

The Company accounts for its stock based compensation in which the Company obtains employee services in share based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 7181030 of the FASB Accounting Standards Codification. Pursuant to paragraph 71810306 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.

 

The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

If the Company is a newly formed corporation or shares of the Company are thinly traded, the use of share prices established in the Company’s most recent private placement memorandum (based on sales to third parties), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black Scholes option pricing valuation model. The ranges of assumptions for inputs are as follows:

 

Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 71810502(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post vesting employment termination behavior into the fair value (or calculated value) of the instruments. Pursuant to paragraph 71810S991, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.
Expected volatility of the entity’s shares and the method used to estimate it. Pursuant to ASC Paragraph 71810502(f) (2)(ii) a thinly traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market
Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk free rates used. The risk free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 

Table Of Contents  

11

 
 

Generally, all forms of share based payments, including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on estimated number of awards that are ultimately expected to vest.

 

The expense resulting from share based payments is recorded in general and administrative expense in the statements of operations.

 

Stock Based Compensation – Non-Employees

 

Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services

 

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 50550 of the FASB Accounting Standards Codification (“Subtopic 50550”).

 

Pursuant to ASC Section 5055030, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. If the Company is a newly formed corporation or shares of the Company are thinly traded the use of share prices established in the Company’s most recent private placement memorandum, or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option pricing valuation model. The ranges of assumptions for inputs are as follows:

 

Expected term of share options and similar instruments: Pursuant to Paragraph 71810502(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder’s expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder’s expected exercise behavior. If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.
Expected volatility of the entity’s shares and the method used to estimate it. Pursuant to ASC Paragraph 71810502(f) (2)(ii) a thinly traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.
Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of riskfree rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 

Table Of Contents  

12

 
 

Pursuant to ASC paragraph 50550257, if fully vested, no forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra equity under the requirements of paragraph 50550451) depends on the specific facts and circumstances. Pursuant to ASC paragraph 50550451, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra equity by the grantor of the equity instruments.

 

The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 5055030 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.

 

Pursuant to Paragraphs 50550258 and 50550259, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a share option and similar instrument that the counterparty has the right to exercise expires unexercised.

 

Pursuant to ASC paragraph 5055030S991, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

 

Revenue Recognition

 

The Company derives revenues from the sale of GE branded fans and lighting fixtures to large retailers through retail and online sales.

 

Revenue is recorded when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) asset is transferred to the customer without further obligation, (3) the sales price to the customer is fixed or determinable, and (4) collectability is reasonably assured.

 

Cost of Sales

 

Cost of sales represents costs directly related to the production and third party manufacturing of the Company’s products.

 

Product sold is typically shipped directly to the customer from the third party manufacturer; cost associated with shipping and handling is shown as a component of cost of sales.

 

Earnings (Loss) Per Share

 

Basic net earnings (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of common stock, common stock equivalents and potentially dilutive securities outstanding during each period.

 

The Company uses the “treasury stock” method to determine whether there is a dilutive effect of outstanding convertible debt, option and warrant contracts. For the nine months ended September 30, 2016 and 2015, the Company reflected net loss and a dilutive net loss, and the effect of considering any common stock equivalents would have been antidilutive for the period. Therefore, separate computation of diluted earnings (loss) per share is not presented for the periods presented.

 

The Company has the following common stock equivalents at September 30, 2016 and December 31, 2015:

 

Table Of Contents  

13

 
 

 

    September 30, 2016   December 31, 2015
           
Convertible Debt  (Exercise price - $0.25/share)   6,976,935     18,056,935
Stock Warrants (Exercise price- $0.375 - $3.00/share)   12,745,651     9,728,984
Stock Options (Exercise price $0.60 - $3.50/share)   1,350,000     200,000
Total   21,072,586     27,985,919

 

Related Parties

 

The Company follows subtopic 85010 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

 

Pursuant to Section 8501020 the related parties include (a) Affiliates of the Company; (b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) Trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; (d) Principal owners of the Company; (e) Management of the Company; (f) Other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a). the nature of the relationship(s) involved; (b). a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c). the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d). amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Contingencies

 

The Company follows subtopic 45020 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Table Of Contents  

14

 
 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, consolidated financial position, and consolidated results of operations or consolidated cash flows.

 

Subsequent Events

 

The Company follows the guidance in Section 8551050 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.

 

Pursuant to ASU 201009 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

 

Recently Issued Accounting Pronouncements

 

In April 2015, the FASB issued Accounting Standards Update No. 201503, Interest—Imputation of Interest (Topic 83530): Simplifying the Presentation of Debt Issuance Costs (“ASU 201503”). ASU 201503 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs is not affected by ASU 201503. ASU 201503 is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. The Company has reclassified debt issuance costs from prepaid expenses and other current assets and other assets as a reduction to debt in the condensed consolidated balance sheets.

 

In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 201511, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 201511”), which applies guidance on the subsequent measurement of inventory. ASU 201511 states that an entity should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal and transportation. The guidance excludes inventory measured using last-in, first-out or the retail inventory method. ASU 201511 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company is not planning to early adopt ASU 201511 and is currently evaluating ASU 201511 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

 

Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company’s financial position, results of operations or cash flows.

 

Note 3 Furniture and Equipment

 

Property and equipment consisted of the following at September 30, 2016 and December 31, 2015:

 

 

   

 

September 30, 2016

(Unaudited)

 

December 31, 2015

(Audited)

                 
Office Equipment   $ 146,162     $ 136,611  
Furniture and Fixtures     31,848       30,561  
Total     178,010       167,172  
Less: Accumulated Depreciation     (59,365)       (39,651)  
Property and Equipment - net   $ 118,645     $ 127,521  

 

Table Of Contents  

15

 
 

 

Depreciation expense amounted to $6,707 and $19,714 for the three and nine months ended September 30, 2016; and $5,603 and $16,471 for the three and nine months ended September 30, 2015, respectively.

 

Note 4 Intangible Assets

 

Intangible assets (patents) consisted of the following at September 30, 2016 and December 31, 2015:

 

 

   

September 30, 2016

(Unaudited)

 

December 31, 2015

(Audited)

                 
Patents   $ 126,669     $ 103,792  
Less: Impairment Charges     —         —    
Less: Accumulated Amortization     (26,392)       (20,618)  
Patents - net   $ 100,277     $ 83,174  

 

Amortization expense associated with patents amounted to $2,095 and $5,774 for the three and nine months ended September 30, 2016, respectively, and $1,384 and $3,705 for the three and nine months ended September 30, 2015, respectively.

 

At September 30, 2016, future amortization of intangible assets:

 

Year Ending December 31        
2016     $ 2,129
2017       8,445
2018       8,445
2019       8,445
2020       8,468
2021 and Thereafter       64,345
      $ 100,277

 

Actual amortization expense in future periods could differ from these estimates as a result of future acquisitions, divestitures, impairments and other factors.

 

Note 5 GE Trademark License Agreement

 

The Company entered into an amended License Agreement with General Electric regarding the GE Trademark License. The License Agreement is amortized through its expiration in November 2018.

 

   

September 30, 2016

(Unaudited)

 

December 31, 2015

(Audited)

GE Trademark License   $ 12,000,000     $ 12,000,000
Less: Impairment Charges     —            —  
Less: Accumulated Amortization     (6,709,030)       (4,876,254)
Patents – net   $ 5,290,970     $ 7,123,746

 

Amortization expense associated with the GE Trademark License amounted to $615,385 and $1,832,776 for the three and nine months ended September 30, 2016, respectively, and $615,385 and $1,826,087 for the three and nine months ended September 30, 2015, respectively.

 

Table Of Contents  

16

 
 

At September 30, 2016, future amortization of intangible assets is as follows for the remaining:

 

Year Ending December 31
  2016     $ 615,385  
  2017       2,441,472  
  2018       2,234,113  
        $ 5,290,970  

 

Note 6 Notes Payable

 

At September 30, 2016 and December 31, 2015, the Company had a note payable to a bank in the amount of $216,170 and $301,744, respectively. The note, dated May 2007, is due in monthly payments of $10,000 and carries interest at 4.75%. The note is secured by the assets of the Company and personal guarantees by a shareholder and an officer of the Company, and is due August 2018.

 

On April 13, 2016, the company entered in to an agreement with a third party for a $10,000,000 line of credit. The primary purpose of this line of credit is to fund manufacturing and product related obligations. The note carries interest of 8%, due monthly with principal and unpaid interest due December 31, 2017. The note is secured by the assets of the company. The outstanding balance on this note was $3,006,124 at September 30, 2016.

 

Principal payments due under the terms of this note are as follows:

 

Principal Due in Next 12 months        
2016     $ 111,894
2017       3,110,400
      $ 3,222,294

 

The Company received a $500,000 loan from a related party in January 2016. The note is on demand and carries interest of 12%. As of September 30, 2016 the outstanding balance is $200,000.

 

Note 7 Convertible Debt Net

 

The Company has recorded derivative liabilities associated with convertible debt instruments, as more fully discussed at Note 8.

 

    Third Party   Related Party   Totals
 Balance December 31, 2014   $ 1,911,995     $ 26,999     $ 1,938,994  
Add: Amortization of Debt Discount     2,077,955       23,001       2,100,956  
Balance December 31, 2015     3,989,950       50,000       4,039,950  
Add: Amortization of Debt Discount     474,283       —         474,283  
Less Repayments/Conversions     (2,770,000)       —         (2,770,000)  
Balance June 30, 2016     1,694,233       50,000       1,744,234  
Less Current portion     (1,694,233)       (50,000)       (1,744,234)  
Long-Term Convertible Debt   $ —       $ —       $ —    

 

Table Of Contents  

17

 
 

On November 26, 2013, May 8, 2014 and September 25, 2014 the Company completed closings in connection with its offering (the “Notes Offering”) of its 12% Secured Convertible Promissory Notes (the “12% Notes”) in the aggregate principal amount of $4,240,100 and/or its 15% Secured Convertible Promissory Notes in the aggregate principal amount of $30,000 (the “15% Notes”, and together with the 12% Notes, each a “Note” and collectively, the “Notes”), as applicable, with certain “accredited investors” (the “Investors”), as defined under Regulation D, Rule 501 of the Securities Act. The entire aggregate principal amount of the Notes of $3,574,234 outstanding as of September 30, 2016 and $4,270,100 was outstanding as of December 31, 2015, such amount being exclusive of securities converted into the Notes separate from the Notes Offering. Pursuant to the Notes Offering, the Company received $1,752,803, $1,400,000 and $800,500 in net proceeds on November 26, 2013, May 8, 2014 and September 25, 2014, respectively.

 

In addition to the terms customarily included in such instruments, the Notes began accruing interest on the date that each Investor submitted the principal balance of such Investor’s Note, with the interest thereon becoming due and payable on the one year anniversary, and quarterly thereafter. Upon a default of the Notes, the interest rate will increase by 2% for each 30 day period until cured. The principal balance of each Note and all unpaid interest became payable twenty-four (24) months after the date of issuance. The principal and outstanding interest under the Notes are convertible into shares of the Company’s common stock at $0.25 per share and are secured by a first priority lien (subject only to an existing note with Signature Bank of Georgia on the Company’s intellectual property and all substitutes, replacements and proceeds of such intellectual property) pursuant to the terms of a Security Purchase Agreement, dated as of November 26, 2013, May 8, 2014 and September 25, 2014, as applicable, by and between the Company and each Investor.

 

Pursuant to the Notes Offering, each Investor also received five (5) year common stock warrants to purchase the Company’s common stock at $0.375 per share (each a “Warrant” and collectively, the “Warrants”). Investors of the 12% Notes received Warrants with 25% coverage based on a predetermined valuation of the Company. Investors of the 15% Notes received Warrants with 15% coverage based on the predetermined valuation of the Company. Investors with a principal investment amount equal to or greater than $250,000 received Warrants with a bonus 40% coverage (“Bonus Coverage”); however, if an Investor previously invested $250,000 or more in the Notes Offering, such Investor received Bonus Coverage if such Investor subsequently invested $100,000 or more in the Notes Offering. In addition to the terms customarily included in such instruments, the Warrants may be exercised by the Investors by providing to the Company a notice of exercise, payment and surrender of the Warrant.

 

The Notes and Warrants were treated as derivative liabilities.

 

In connection with the Notes Offering, the Company entered into Registration Rights Agreements, each dated as of November 26, 2013, May 8, 2014 and September 25, 2014, and each by and between the Company and each of the Investors (collectively, the “Registration Rights Agreements”), whereby the Company agreed to prepare and file a registration statement with the SEC within sixty (60) days after execution of the applicable Registration Rights Agreement and to have the registration statement declared effective by the SEC within ninety (90) days thereafter.

 

Because the Company was unable to file a registration statement pursuant to the terms of each Registration Rights Agreements dated as of November 26, 2013 or May 8, 2014, the Company was in default under such Registration Rights Agreements (the “Filing Default Damages”), and because the Company was unable to have a registration statement declared effective pursuant to the terms of the Registration Rights Agreements dated as of November 26, 2013, the Company was in default under such Registration Rights agreements (the “Effectiveness Default Damages”). The Filing Default Damages stopped accruing on the date such registration statement was filed, and the Effectiveness Default Damages stopped accruing on the date it was declared effective.

 

Table Of Contents  

18

 
 

The Company invited the Investors holding Notes dated November 26, 2013 to extend the first interest payment that was scheduled to be paid pursuant to the Notes dated November 26, 2013 (the “Interest Due”) to February 24, 2015 and in exchange offered to capitalize the Interest Due at a rate of 12% through payment (the “Additional Interest”), all of which was convertible into the Company’s common stock at a price of $0.25 per share. Through September 30, 2016, the Company has issued in total 2,343,191 shares of its common stock representing $585,798 in Additional Interest, Interest Due, Filing Default Damages and Effectiveness Default Damages. As of September 30, 2016, all Additional Interest, Interest Due, Filing Default Damages and Effectiveness Default Damages was repaid by the Company.

 

During 2015, five Investors requested that the Company withhold payments of interest due under their Notes at no cost to the Company, to allow the Company to address working capital needs. Such interest due has been or will be paid to the five Investors, and none of such amounts have been or will be paid in shares of the Company’s capital stock.

 

In November 2015, the Company invited the holders of Notes dated November 26, 2013, with respect to outstanding principal and interest due under their respective Notes, to (i) receive payment in cash, (ii) convert their Notes into shares of the Company’s common stock, or (iii) forbear an election for three (3) months, or until February 26, 2016, pursuant to a forbearance agreement, during such time interest under their respective Notes would continue to accrue. In February 2016, the Company invited the same holders to extend their forbearance period to make an election to convert or redeem their Notes for an additional three months, or until May 26, 2016, under the same terms as the first forbearance agreement.   In May 2016, the Company invited the holders of all Notes, where such holders had not already made an election to redeem or convert their Notes, to forbear or extend their forbearance period to make an election to convert or redeem their Notes until July 31, 2016, which the Company thereafter extended to August 15, 2016 (the “August 2016 Election”). This also provided a third option to all noteholders, whereby such holders could convert their respective Note(s) into shares of Series A Convertible Preferred Stock (“Preferred Stock”).

 

Table Of Contents  

19

 
 

 

As of September 30, 2016, The Company received elections, in connection with the August 2016 Election, to (i) convert three (3) Notes into 240,000 shares of common stock of the Company representing an aggregate principal balance of $60,000, and (ii) convert 33 Notes into 13,456,936 shares of Preferred Stock representing an aggregate principal balance of $3,364,234. The Company received no elections in connection with the August 2016 Election to redeem Notes. Two (2) Investors holding Notes representing an aggregate principal balance of $100,000 have not responded to the August 2016 Election. Other than the two (2) aforementioned Investors, all Investors had elected to redeem or convert their Notes into shares of common stock or Preferred Stock.

 

All issuances of capital stock in the August 2016 Election have been or will be made only for principal balances due under the Notes, and all interest has been or will be paid directly to the Investors.

 

See Note 14, Subsequent Events, for additional information.

 

(A) Terms of Debt

 

The debt carries interest between 12% and 15%, and was due in November 2015, May 2016 and September 2016, as extended to July 31, 2016 pursuant to certain forbearance agreements.

 

All Notes and Warrants issued in connection with the Notes Offering are convertible at $0.25 and $0.375/share, respectively, subject to the existence of a “ratchet feature”, which allows for a lower offering price if the Company offers shares to the public at a lower price.

 

(B) Future Commitments

 

At September 30, 2016, the Company has outstanding convertible debt of $1,744,233, which is payable within the next twelve months.

 

(C) Offer to Convert Debt to Preferred Shares

 

By letter to each holder of the Notes, dated July 22, 2016, the Company requested that each holder indicate its election to (i) redeem its Note, (ii) convert its Note into the Company’s common stock or (iii) elect to convert its Note into shares of Preferred Stock (the “Preferred Option”), in each case by August 15, 2016.

 

For those holders electing the Preferred Option, each holder has received or will receive shares of the Preferred Stock on a 1 to 1 ratio to the number of shares of the Company’s common stock which are then convertible under such holder’s respective Note. With respect to interest on junior securities, dividends, distributions or liquidation preference, shares of Preferred Stock will rank senior to shares of the Company’s common stock or other junior securities. Along with other terms customary for a class of convertible preferred stock, the Preferred Stock will be convertible into shares of the Company’s common stock at the same conversion price as the Notes (i.e., USD $0.25 per share), and will pay interest quarterly at a rate of six percent (6%). The Preferred Stock will be convertible upon the election of the holder thereof. Shares of the Preferred Stock may be repurchased by the Company upon 30 days’ prior written notice, in whole or in part, for USD $3.50 per share, provided that during such notice period the holder will continue to have the option and right to convert its shares of Preferred Stock into shares of the Company’s common stock. Holders will also have a put option, allowing them to sell their shares of Preferred Stock back to the Company at USD $0.25 per share, the Note conversion price.

 

Each holder electing the Preferred Option was required to enter into an amendment to its Note, providing that the Note will be convertible into the Preferred Stock rather than the Company’s common stock, and to thereafter elect to convert their Note, as amended, into Preferred Stock. In addition, each holder will be required to enter into a lockup agreement, whereby the holder will agree not to offer, sell, contract to sell, pledge, give, donate, transfer or otherwise dispose of (i) the shares of the Company’s common stock it then holds, (ii) the shares of Preferred Stock obtained upon conversion of its Note, and (iii) the shares of the Company’s common stock underlying the Preferred Stock. The Note amendments, conversion to Preferred Stock and lockup agreement have been entered into on August 15, 2016. The Note amendments were approved by a majority of the holders of the then outstanding Notes.

 

Table Of Contents  

20

 
 

During the quarter ended September 30, 2016, noteholders converted $1,770,000 in convertible debt under the Notes into 7,080,000 of Preferred Stock pursuant to the Preferred Option, and the Company had received elections to convert an additional $1,594,234 in convertible debt under the Notes into 6,376,936 shares of Preferred Stock upon receipt of complete paperwork and original Notes (or in the alternative, a Declaration of Loss of Security) from the respective noteholders. All issuances of Preferred Stock pursuant to the Preferred Option have been or will be made only for principal balances due under the Notes, and all interest has been or will be paid directly to the noteholders.

 

Note 8 Derivative Liabilities

 

The Company identified conversion features embedded within convertible debt and warrants issued in 2013 and 2014. The Company has determined that the features associated with the embedded conversion option, in the form a ratchet provision, should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions.

 

As a result of the application of ASC No. 815, the fair value of the ratchet feature related to convertible debt and warrants is summarized as follow:

 

The fair value at the commitment and re-measurement dates for the Company’s derivative liabilities were based upon the following management assumptions as:

 

    September 30, 2016   December 31, 2015
Balance Beginning of period   $ 24,157,838     $ 5,140,758  
 Reclassification of derivative liabilities to additional paid in capital related to warrants exercised that ceased being a derivative liability     -       (189,613)  
Extinguishment of Derivative Liability - Conversion of Interest to Shares     -       (209,604)  
 Fair value mark to market adjustment - stock options     (743,624)       134,162  
Fair value at the commitment date for options granted     2,446,918       -  
 Fair value mark to market adjustment - convertible debt     39,604,884       18,835,664  
 Fair value mark to market adjustment - warrants     (1,467,629)       446,471  
Fair value at commitment date for warrants issued     4,963,451       -  
Debt settlement on the derivative liability associated with interest     (180,783)       -  
Reclassification of derivative liability to Additional Paid In Capital due to share reservation     (45,015,362)       -  
Fair value mark to market adjustment for interest     1,251,167       -  
Balance at end of period   $ 25,016,860     $ 24,157,838  

 

      Commitment Date       Recommitment Date  
Expected dividends     0 %     0 %
Expected volatility     150 %     150 %
Expected term     2-5 years       0.00 – 3.24 years  
Risk Free Interest Rate     .29%-2.61%       .21%-.88%  

 

Table Of Contents  

21

 
 

Note 9 Debt Discount

 

The Company recorded the debt discount to the extent of the gross proceeds raised, and expensed immediately the remaining fair value of the derivative liability, as it exceeded the gross proceeds of the note.

 

Accumulated amortization of derivative discount amounted to $4,402,773 as of September 30, 2016 and $4,153,611 for the year ended December 31, 2015.

 

The Company recorded a change in the value of embedded derivative liabilities income   /(expense) of ($3,183,183) and ($7,993,408) for the three months ended September 30, 2016 and 2015, respectively, and ($38,644,799) and ($7,357,719) for the nine months ended September 30, 2016 and 2015, respectively.

 

The Company recorded derivative expense of ($2,446,918) and $0 for the three months ended and ($7,410,369) and $0 for the nine months ended September 30, 2016 and 2015, respectively.

 

The Company recorded loss on disposition of debt as a result of conversion to Common Stock and Preferred Stock of ($22,121,217). The loss was a result of the conversion value of the shares received exceeded the face value of the note.

 

Note 10 Debt Issue Costs

    September 30, 2016   December 31, 2015
  (Unaudited)   (Audited)
Debt Issuance Costs   $ 316,77     $ 316,77  
Total     316,77       316,77  
Less: Accumulated Amortization     316,77       (302,192 )
Debt Issuance Costs   $ —       $ 14,605  

 

 

The Company recorded amortization expense of $0 and $39,441 for the three months ended September 30, 2016 and 2015, respectively, and $14,605 and $117,098 for the nine months ended September 30, 2016 and 2015, respectively.

 

Note 11 GE Royalty Obligation

 

In 2011, the Company executed a Trademark Licensing Agreement with General Electric, which allows the Company the right to market certain ceiling light and fan fixtures displaying the GE brand. The License Agreement imposes certain manufacturing and quality control conditions that the Company must maintain in order to continue to use the GE brand.

 

The License Agreement is nontransferable and cannot be sublicensed. Various termination clauses are applicable, however, none were applicable as of September 30, 2016 and December 31, 2015.

 

In August 2014, the Company entered into a second amendment to the License Agreement pertaining to its royalty obligations. Under the terms of the amendment, the Company agreed to pay a total of $12,000,000 by November 2018 for the rights assigned in the original contract. In case the Company does not pay GE a total of at least $12,000,000 in cumulative royalties over the term of the License Agreement, the difference between $12,000,000 and the amount of royalties actually paid to GE is owed in December 2018.

 

Table Of Contents  

22

 
 

Payments are due quarterly based upon the prior quarters’ sales. The Company made payments of $319,170 and $170,699 for the nine months ended September 30, 2016 and 2015, respectively.

 

The License Agreement obligation will be paid from sales of GE branded product subject to the following repayment schedule:

 

Net Sales in Contract Year Percentage of Contract Year Net Sales owed to GE  
$0 $50,000,000   7%
$50,000,001 $100,000,000   6%
$100,000,000+   5%

 

The Company has limited operating history and does not have the ability to estimate the sales of GE branded product, the liability is classified as long-term. As sales are recognized, the Company will estimate the portion it expects to pay in the current year and classify as current.

 

Note 12 Stockholders Deficit

 

(A) Common Stock

 

For the nine months ended September 30, 2016 and year ended December, 31 2015, the Company issued the following common stock:

 

Transaction Type       Quantity   Valuation   Range of Value per Share
2015 Equity Transactions                              
                               
Common stock issued per Waiver and Conversion Agreement     (1)     $ 1,718,585     $ 429,646     $ 0.25
                               
Common stock issued per Employment Agreement of CEO     (2)       750,000       173,688       0.25
                               
Common stock issued per Stock Rights Offering     (3)       3,782,666       2,210,032       0.60
                               
Common stock issued per Stock Rights Offering- to be issued     (4)       500,000       500,000       1.00
December 31 2015             6,751,251     $ 3,313,366     $ 0.25-1.00
Common Stock issued Board of Directors Compensation     (5)                 62,000              42,000       0.60-1.00
                               
Common stock issued per Waiver and Conversion Agreement     (6)            1,790,092            822,524       0.25-.625
                               
Common Stock offering     (7)            3,155,000         7,538,000       1.00-2.70
                               
Common Stock Award     (8)                 25,000              15,000       0.60
                               
Common Stock Issued for Services     (9)               300,000            136,250       0.25-1.00
                               
 Common Stock Issued for Conversion of Debt     (10)               243,156            816,789        
                               
September 30, 2016                  5,575,248     $   9,370,563     $ 0.25-2.65

 

Table Of Contents  

23

 
 

The following is a more detailed description of the Company’s stock issuance from the table above:

 

(1) Agreement and Waiver and Agreement to Convert

 

The Company issued 1,718,585 shares at $0.25 per share, representing $429,646 in penalties and interest, in connection with the Agreement and Waiver and the Agreement to Convert. For a complete description of the Agreement and Waiver and the Agreement to Convert, see Note 7 above.

 

(2) Shares Issued to Chief Executive Officer

 

In November 2014, the Company entered into an Employment Agreement with its current Chief Executive Officer, which provided for stock based compensation equal to 750,000 of restricted shares, of which 250,000 shares vested in May 2015 and 500,000 shares vested in December 2015. These shares were issued at $0.25 per share and were issued subsequent to December 31, 2015.

 

(3) Shares Issued in Connection with Stock Offering

 

In May 2015, the Company offered to existing shareholders a maximum of 6,666,667 shares of common stock at an issuance cost of $0.60 per share for a total of $4,000,000 (the “May Stock Offering”). The May Stock Offering concluded on November 15, 2015 the Company will issue 3,782,666 shares in connection with three closings.

 

(4) Shares Issued in Connection with Stock Offering

 

In November 2015, the Company offered to new and existing shareholders a maximum of 2,000,000 shares of common stock at an issuance cost of $1.00 per share for a total of $2,000,000 (the “November Stock Offering”). On December 24, 2015, the Company closed subscriptions for 500,000 shares of common stock pursuant to the November Stock Offering, and on January 4, 2016, the stock certificates representing those shares were issued. Shares Issued in Board of Directors Compensation.

 

(5) Shares issued to Board of Directors

 

The Company added a new Director in November 2015. The Company issued the Director 50,000 shares of Common Stock at $0.60 per share as compensation in February 2016. In addition, this Director agreed to serve as the Company’s Audit Committee Chair, and received 12,000 shares of Common Stock at $1.00 per share as compensation for these additional responsibilities.

 

(6) Shares Issued in Connection with the Notes or Agreements to Convert

 

In connection with the Agreement and Waiver and Agreement to Convert, as of the nine months ended September 30, 2016, the Company issued an additional 2,343,191 shares of its common stock as payment for Additional Interest, Interest Due, Filing Default Damages and Effectiveness Default Damages, representing payment to Investors of $585,798.

 

Table Of Contents  

24

 
 

(7) Shares Issued in Connection with Offering

 

On February 19, 2016, the Company completed a second closing of the November Stock Offering representing aggregate gross proceeds to the Company of $300,000, and thereafter issued 300,000 shares of its common stock.

 

In April 2016, the Company completed an offering of 2,000,000 shares at an offering price of $2.50 and 1,666,667 in warrants with a conversion price of $3.00 per share.

 

In May 2016, the Company completed an offering of 675,000 shares at an offering price of $2.60 and 1,350,000 of warrants with a conversion price between $3.00 and $3.50 over the next three anniversary dates.

 

In July 2016 the Company completed an offering for 30,000 shares at $2.60 and an additional 150,000 shares at $2.70 in two separate offerings.

 

(8) Shares Issued Pursuant to Stock Awards.

 

In September 2016, the Company issued 25,000 shares in stock awards at $0.60 per share.

 

(9) Shares Issued for Services

 

In September 2016, the Company issued 300,000 shares issued representing $136,250 in services received. The share conversions were in a range of $0.25 to $1.00 per share.

 

(10) Shares Issued in Conjunction with Retirement of Debt

 

In accordance with the Notes, 243,156 shares were issued for the retirement of debt during the period.

 

(B) Stock Options

 

The following is a summary of the Company’s stock option activity:

            Weighted Average   Aggregate
        Weighted Average   Remaining Contractual Life   Intrinsic
    Options   Exercise Price   (In Years)   Value
Balance- December 31, 2014     200,000       0.375       2.18     $ 324,829  
Exercised     —         —         —         —    
Granted     —         —         —         —    
Forfeited/Cancelled     —         —         —         —    
Balance- December 31, 2015     200,000       0.375       2.18     $ 324,829  
Exercised     —         —         —         —    
Granted     1,150,000       0.835       1.38     $ 1,700,000  
Forfeited/Cancelled     —         —         —         —    
Balance- September 30, 2016     1,350,000       0.835       1.38     $ 1,700,000  

 

Table Of Contents  

25

 
 

(C) Warrants Issued

 

The following is a summary of the Company’s stock option activity:

  

  Number of Warrants     Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years)
           
Balance, December 31, 2014 9,728,984     0.375 3.9
Exercised —       —   —  
Cancelled/Forfeited —       —   —  
Balance, December 31, 2015 9,728,984   $ 0.375 3.2
Issued 3,016,667   $ 3.45 1.68
Exercised —       —   —  
Cancelled/Forfeited —       —   —  
Balance, September 30, 2016 12,745,651   $ 1.1 3.37

 

(D) 2015 Stock Incentive Plan

 

On April 27, 2015, the Board approved the Company’s 2015 Stock Incentive Plan (the “Incentive Plan”). Under the Incentive Plan, the Board has the sole authority to implement, interpret, and/or administer the Incentive Plan unless the Board delegates all or any portion of its authority to implement, interpret, and/or administer the Incentive Plan to a committee of the Board, or (ii) the authority to grant and administer awards under the Incentive Plan to an officer of the Company. The Incentive Plan relates to the issuance of up to 5,000,000 shares of the Company’s common stock, subject to adjustment, and shall be effective for ten (10) years, unless earlier terminated. Certain options to be granted to employees under the Incentive Plan are intended to qualify as Incentive Stock Options (“ISOs”) pursuant to Section 422 of the Internal Revenue Code of 1986, as amended, while other options granted under the Incentive Plan will be nonqualified options not intended to qualify as Incentive Stock Options ISOs (“Nonqualified Options”), either or both as provided in the agreements evidencing the options described.

 

The Incentive Plan further provides that awards granted under the Incentive Plan cannot be exercised until a majority of the Company’s shareholders have approved the Incentive Plan. The Incentive Plan which became effective July 31, 2016

 

(D) Issuance of Convertible Preferred Stock

 

During the quarter ended the Company offered current note holders the convert their shares to Preferred Stock (see Note 7 (C   )). In conjunction with that offered the company issued 7,080,000 shares of Preferred Stock value of $24,072,000. The valuation was based on a share price of $3.40 which was the closing price on the OTC of the Company’s stock on September 1, 2016.

 

Note 13 Commitments

 

(A) Operating Lease

 

In January 2014, the Company executed a 39 month lease for a corporate headquarters. The Company paid a security deposit of $27,020.

 

In October, 2014, the Company executed a 53 month lease for a new corporate headquarters with a base rent of $97,266 escalating annually through 2019. The Company paid a security deposit of $1,914.

 

In October, 2014, the Company entered into a sublease agreement to sublease its previous office space through March 2017. In connection with the sublease, the Company collected $34,981 as a security deposit.

 

The minimum rent obligations are approximately as follows:

 

Table Of Contents  

26

 
 

    Minimum   Sublease   Net
Year   Obligation   Rentals   Obligation
2016   16,418   -   16,418
2017   65,700   -   65,700
2018   66,508   -   66,508
2019   22,384    -   22,384
             
Total $ 171,010 $ - $ 171,010

 

(B) Employment Agreement Chief Executive Officer

 

In November 2014, the Company entered into an employment agreement with its new Chief Executive Officer. In addition to salary, the agreement provided for the issuance of 750,000 restricted shares of the Company’s common stock to him, which vested and were issued as follows: 250,000 shares after the first 6 months of employment and 500,000 additional shares at December 31, 2015. Under terms of the agreement the executive would receive additional compensation in the form of stock options to purchase shares of Company stock equal to one half of one percent (0.5%) of quarterly net income. The strike price of the options will be established at the time of the grant. The options will vest in twelve months and expire after sixty months. In addition to the stock options compensation, the executive will receive cash compensation equal to one half of one percent (0.5%) of annual sales up to $20 million and one quarter of one percent (0.25%) for annual sales $20 million and 3% of annual net income.

 

On September 1, 2016, the Company entered into a new employment agreement with Mr. Campi. The agreement provides for a base salary of $150,000; 120,000 shares of The Company’s common stock in a “Sign On Bonus” which will vest December 31, 2017; 0.25% of annual gross sales and 3% of annual adjusted gross income in cash compensation and 0.50% of quarterly net income in options, the strike price to be determined at the time of grant. Such options will expire 5 years after issuance.

 

For the nine months ended September 30, 2016 and 2015, Mr. Campi earned approximately $23,000 and $11,000 respectively, under this agreement. No stock or options have been issued.

 

(C) Chairman Agreement

 

The Company has a 3 year consulting agreement with a director which expires in November 2016, and carries an annual payment of $150,000 cash, stock or 5 year options equal to one half of one percent (0.5%) of the Company’s annual net sales. For the nine months ended September 30, 2016 and 2015, Mr. Kohen earned approximately $28,000 and $11,000, respectively, under this agreement. No stock or options have been issued.

 

On September 1, 2016 the Company modified the above agreement. The compensation was changed to $250,000 per annum, an annual grant of the Company’s common stock of 340,000 shares which vest in its entirety January 1, 2019; Stock options equal to .005% of the Company’s gross revenue with 5 year vesting. In addition the Chairman was granted a “Sign On Bonus” of 120,000 shares of the Company’s common stock which will vest January 1, 2020 and a supplemental bonus of options which is tied to the stock performance of the Company.

 

(D)       Employment Agreement – President

 

On August 16, 2017 the Company entered into an Employment Agreement with Mark Wells, its new President. Mr   . Wells receives a salary of $250,000; 1,025,000 shares in the Company’s common stock which will vest in its entirety January 1, 2019; 0.25% of the Company’s net revenue and a “Sign on Bonus” of 120,000 shares of the Company’s common stock which vests January 1, 2017. For the nine months ended September 30, 2016, Mr. Wells was issued 100,000 shares of the Company’s common stock and earned $10,000 in commissions pursuant to the terms of a Consulting Agreement, dated June 1, 2015, between the Company and Mr. Wells, whereby Mr. Wells provided independent sales consultant services.

 

  (D) Employment Agreement – Chief Operating Officer

 

Effective July 1, 2016, the Company entered into an Executive Employment Agreement with Patricia Barron, its Chief Operations Officer. Ms. Barron receives a base salary of $120,000 per year   and incentive compensation equal to 0.25% of the Company’s net revenue paid in cash. For the nine months ended September 30, 2016, Ms. Barron earned approximately $5,100 under this agreement.

 

 

Table Of Contents  

27

 
 

Note 14 Subsequent Events

 

Since October 1, 2016, the Company has issued 5,576,936 shares of Preferred Stock, representing $1,394,234 in Note principal. In total from August 15, 2016 through November 14, 2016, the Company has issued 240,000 shares of its common stock, representing $60,000 in Note principal, and 12,656,936 shares of Preferred Stock, representing $3,164,234 in Note principal, in connection with the August 2016 Election. The Company will issue an additional 800,000 shares of Preferred Stock, representing $200,000 in Note principal, upon receipt of complete paperwork and original Notes (or in the alternative, a Declaration of Loss of Security) from the respective Investors. All issuances of capital stock in the August 2016 Election will be made only for principal balances due under the Notes, and all interest has been or will be paid directly to the Investors.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS

 

You should read the following discussion and analysis in conjunction with our unaudited condensed consolidated financial statements and related notes contained in Part I, Item 1 of this report.

 

Forward-Looking Statements

 

The information set forth in this Quarterly Report contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, including, among others (i) expected changes in SQL Technologies Corp’s. revenues and profitability, (ii) prospective business opportunities and (iii) our strategy for financing its business. Forward-looking statements are statements other than historical information or statements of current condition. Some forward-looking statements may be identified by use of terms such as “believes”, “anticipates”, “intends” or “expects”. These forward-looking statements relate to our plans, objectives and expectations for future operations. Although we believe that our expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of our knowledge of our business and operations, in light of the risks and uncertainties inherent in all future projections, the inclusion of forward-looking statements in this Quarterly Report should not be regarded as a representation by us or any other person that our objectives or plans will be achieved. Our revenues and results of operations could differ materially from those projected in the forward-looking statements as a result of numerous factors, including, but not limited to, the following: the risk of significant natural disaster, the inability of the Company to insure against certain risks, inflationary and deflationary conditions and cycles, currency exchange rates, and changing government regulations domestically and internationally affecting our products and businesses.

 

We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements. You should read the following discussion and analysis in conjunction with the Financial Statements and Notes attached hereto, and the other financial data appearing elsewhere in this Quarterly Report.

 

US Dollars are denoted herein by “USD”, “$” and “dollars”.

 

Overview

 

We are a company engaged in the business of developing proprietary technology that enables a quick and safe installation by the use of a weight bearing power plug for electrical fixtures, such as light fixtures and ceiling fans, into ceiling and wall electrical junction boxes. Our patented technology consists of a fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a non-conductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug, also comprised of a non-conductive body that houses corresponding conductive rings, attaches to the socket via a male post and is capable of feeding electric power to an appliance. The plug also includes a second structural element allowing it to revolve with a releasable latching which, when engaged, provides a retention force between the socket and the plug to prevent disengagement. The socket and plug can be detached by releasing the latch, disengaging the electric power from the plug. The socket is designed to replace the support bar incorporated in electric junction boxes, and the plug can be installed in light fixtures, ceiling fans and wall sconce fixtures. The combined socket and plug technology is referred to as the “SQL Technology” throughout this prospectus.

 

Table Of Contents  

29

 
 

We currently manufacture and sell ceiling fans and lighting fixtures branded with the General Electric Corporation (“General Electric” or “GE”) logo and manufactured under GE’s strict guidance, pursuant to a trademark license agreement between us and General Electric (the “License Agreement”). Our ceiling fans and lighting fixtures offer unique designs, and are manufactured with and without the SQL Technology.

 

Also in furtherance of our business model, the Company has actively developed trade distribution channels with key retailers, undergone a corporate restructuring, established and obtained authorizations for our third party manufacturers to produce the SQL Technology, and raised the necessary capital resources to implement our business model over the next twelve months.

 

Results of Operations – For the Three-Months Ended September 30, 2016 Compared to the Three-Months Ended September 30, 2015

 

    September 30, 2016   September 30, 2015   $ Change   % Change
                 
Revenue   $ 1,932,312     $ 262,897     $ 1,669,415       635.0 %
                                 
Cost of sales     (1,593,926)       (248,675)       (1,345,251)       541.0 %
                                 
Gross loss     338,386       14,222       324,164       2279.3 %
                                 
General and administrative expenses     (1,613,880)       (1,220,844)       393,036       32.2 %
                                 
Loss from Operations     (1,275,494)       (1,206,622)       (68,872)       5.7 %
                                 
Other Income / (Expense)     (27,886,594)       (8,873,802)       (19,012,792)       214.3 %
                                 
Net Loss   $ (29,162,088)     $ (10,080,424)     $ (19,081,664)       189.3 %
                              .  
Net loss per share - basic and diluted     (0.62)       (0.25)       (0.37)       148.0 %

 

Revenue

We had revenue of $1,932,312 for the three-month period ended September 30, 2016, as compared to revenue of $262,897 for the three-month period ended September 30, 2015.

 

Cost of Sales

We had a cost of sales of $1,593,926 for the three-month period ended September 30, 2016, as compared to a cost of sales of $248,675 for the three-month period ended September 30, 2015. The increase is associated with the increase in sales.

 

Gross Profit

We had gross profit of $338,386 for the three-month period ended September 30, 2016, as compared to gross profit of $14,222 for the three-month period ended September 30, 2015. The increase in gross profit as a percent of sales of 17.5% for the current quarter compared with 5.4% in the previous year quarter is attributable to the mix of on-line sales as well as better pricing structure as the Company’s relationships with new customers evolve.

 

Table Of Contents  

30

 
 

General and Administrative Expenses

General and administrative expense increased to $1,613,880 during the three-month period ended September 30, 2016, from $1,220,884 for the three-month period ended September 30, 2015.

  

The increases in the general and administrative expenses were primarily due to additional business activity including:

· $124,200 Commission expense associated with increased sales
· $ 63, 200 Warehouse and product quality/production oversite
· $ 51,000 Payroll and related expenses
· $ 49,100 Consulting associated with business and web activities
· $ 47,600 Tooling and trade for manufacturing quality reviews
· $ 15,732 Insurance for liability, Directors and Officers and Health
· $ 13,200 Increased travel

 

Loss from Operations

Loss from operations was $(1,275,494) for the three month period ended September 30, 2016 compared to $(1,206,662) for the same period in the prior year and represents the change in general and administrative expenses offset by the gross profit on sales for the periods presented.

 

Other Income (Expense)

Total other expenses increased $(19,012,792) to $(27,886,594) for the three-month period ended September 30, 2016, from $(8,873,802) for the three-month period ended September 30, 2015. The change is associated with a $(22,302,013) non-cash loss on the extinguishment of convertible debt to Preferred Stock. In the exchange, the value of the convertible debt and its derivatives was recognized   at that time. This was offset by a $4,180,225 reduction in the change in fair value of the embedded derivative liability of remaining notes and an increase of $(2,446,918) in non-cash derivative expense associated with an increase in the value of the Company’s common   stock from $0.60 to $2.70 per share. This increase was offset by a $740,470 decrease in interest expense.

 

Net Loss and Net Loss per Share

The Company’s net loss and net loss per share for the three-month period ended September 30, 2016 was approximately $(29,162,088) and $(10,080,424) per share, respectively, as compared to the three-month period ended September 30, 2015, where net loss was approximately $(0.62) and $(0.25) per share, respectively.

 

Net Loss and Net Loss per Share

The Company’s net loss and net loss per share for the three-month period ended September 30, 2016 was approximately $(29,162,088) and $(10,080,424) per share, respectively, as compared to the three-month period ended September 30, 2015, where net loss was approximately $(0.62) and $(0.25) per share, respectively.

 

Results of Operations – For the Nine-Months Ended September 30, 2016 Compared to the Nine-Months Ended September 30, 2015

 

    For the nine months ended        
    September 30, 2016   September 30, 2015   $ Change   % Change
                 
Revenue   $ 5,534,741     $ 2,482,035     $ 3,052,706       123.0 %
                                 
Cost of sales     (4,848,476)       (2,195,655)       (2,652,821)       120.8 %
                                 
Gross loss     686,265       286,380       399,885       139.6 %
                                 
General and administrative expenses     4,550,323       3,741,198       809,125       21.6 %
                                 
Loss from Operations     (3,864,058)       (3,454,818)       (409,240)       11.8 %
                                 
Other Income / (Expense)     (69,070,279)       (9,631,670)       (59,438,609)       617.1 %
                                 
Net Loss   $ (72,934,337)     $ (13,086,489)     $ (59,847,848)       457.3 %
                              .  
Net loss per share - basic and diluted     (1.63)       (0.34)       (1.29)       379.4 %

 

Table Of Contents  

31

 
 

Revenue

We had recorded revenue of $5,534,741 for the nine-month period ended September 30, 2016, as compared to revenue of $2,482,035 for the nine-month period ended September 30, 2015. The 123.0% increase is due to an increase in business with existing customers and the addition of new customers.

 

Cost of Sales

We had a cost of sales of $4,848,476 for the nine-month period ended September, 30, 2016, as compared to a cost of sales of $2,195,655 for the nine-month period ended September 30, 2015. The increase is associated with the increase in sales.

 

Gross Profit

We had gross profit of $686,265 for the nine-month period ended September 30, 2016, as compared to gross profit of $286,380 for the nine-month period ended September 30, 2015. The increase in gross profit as a percent of sales to 12.4% compares with 11.4% for the same period in 2015 and is attributable to better pricing strategies and mix of on-line sales to large retailers.

 

General and Administrative Expenses

General and administrative expense increased $809,125 to $4,550,323 during the nine-month period ended September 30, 2016 from $3,741,198 for the nine-month period ended September 30, 2015.

 

The increases in the general and administrative expenses were due to the following significant items:

· $145,000 Warehouse and product quality/production oversite
· $132,700 increase in sales commissions
· $108,000 increase in China operations
· $93,600 Payroll and related expenses
· $75,500 Legal expenses associated with public company and offering activity
· $75,100 Consulting associated with business and web activities
· $72,800 Travel and Tooling for China operations
· $55,900 Insurance for liability, Directors and Officers and Health
· $26,800 Rent expense net of sub-lease
· $23,113 Increased travel associated with sales

 

Further, decreases in certain items of general and administrative expenses were attributable to the following:

· $(27,200) Marketing expenses
· $(18,900) Accounting fees

  

Loss from Operations

Loss from operations was $(3,864,058) for the nine month period ended September 30, 2016 compared to $(3,454,818) for the same period in the prior year and represents the increase in general and administrative expenses offset by the increase in gross profit on sales for the periods presented.

 

Table Of Contents  

32

 
 

Other Income (Expense)

Total other expenses increased $(59,847,848) to $(69,070,279) for the nine-month period ended September 30, 2016, from $(9,631,670) for the nine-month period ended September 30, 2015. The change is associated with a $(38,644,799) increase in the charge for fair value of the embedded derivative liability and an increase of $(7,410,369) non-cash derivative expense associated with an increase in the value of the Company’s common stock from $0.60 to 2.70 per share. The Company recorded a $(22,302,013) non-cash loss on extinguishment of debt. The Company’s recent private placement of common stock impacted the Black Scholes calculation of the intrinsic value of the equity component. This increase was offset by a $1,371,261 decrease in interest expense.

 

Net Loss and Net Loss per Share

The Company’s net loss for the nine-month period ended September 30, 2016 was $(72,934,337) or $(1.63) per share, as compared to a net loss of $(13,066,489) or $(0.34) per share for the same period in 2015. The net loss includes non-cash derivative related and debt extinguishment expenses of $(68,932,385) and $(7,357,719) for 2016 and 2015, respectively as detailed above.

 

Interest Expense

 

The following table details the Company’s interest expense components:

 

    For the nine months ended September 30,
    2016   2015
                 
Interest accrued on Notes outstanding.   $ 388,170     $ 517,748  
Interest on Notes Payable     25,632       17,848  
TOTAL INTEREST EXPENSE – Notes Payable     413,802       535,596  
Amortization of Debt Issue Cost     14,605       117,098  
Amortization of Debt Discount     474,283       1,621,257  
    $ 902,690     $ 2,273,951  

 

Liquidity and Capital Resources

 

To date, the Company has not generated sufficient revenue to cover its operating costs and continues to operate with negative cash flow. As a result, the Company has raised additional funds through the sale of its common stock. The Company has also entered into a Line of Credit with a third party which will supply it with $10,000,000 to support its purchase orders, inventory and other working capital needs. As of September 30, 2016 the Company had $6,993,876 available under the Line of Credit. Management believes that with the stock sales consummated and the availability of the working capital Line of Credit, it has sufficient liquidity for the next twelve months.

 

For the nine-months ended September 30, 2016, the Company used $5,336,371 of cash for operations as compared with $2,865,936 used for the same period in 2015. The increase in cash used for operations was due to an increase in the Company’s net loss of $(72,934,337), offset by non-cash expenses of $38,644,799 change in derivative liability, $7,410,369 loss in derivative expense and $22,302,013 loss in early extinguishment of debt. Net funds used for working capital was $2,334,539 due to an increase in accounts receivable and inventory of $(3,509,844), partially offset by an increase of $1,533,106 in accounts payable.

 

For the nine-months ended September 30, 2016, cash flows used ($33,714) for investing activities as compared with ($31,355) used for the same period in 2015. The investments were for patents costs and fixed assets.

 

For the nine months ended September 30, 2016, cash flows provided from financing activities amounted to $9,916,860 in cash equivalents for the nine-months ended September 30, 2016, as compared with $2,323,277 in the same period in 2015.

 

Table Of Contents  

33

 
 

As a result of the above operating, investing and financing activities, the Company provided $4,546,775 in cash equivalents for the nine-months ended September 30, 2016, as compared with ($574,014) used during the same period in 2015. The Company had $4,997,643 in cash and cash equivalents at September 30, 2016 as compared to $667,473.

 

The Company had a working capital deficit of $(22,727,265) as of September 30, 2016, as compared to $(28,174,512) as of December 31, 2015 which includes $(25,016,860) in derivative liabilities and an increase in inventory and accounts receivable, offset by an increase in accounts payable.

 

A majority of the Company’s sales do not require the Company to take delivery of inventory. Production of the SQL Technology and fixtures will be originated upon receipt of FOB (free on board) purchase contracts from customers. Upon the completion of each purchase contract, the finished products will be transported from the manufacturer directly to the ports and loaded on vessels secured by the customer, upon which the products become the property of the customer.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements.

 

Critical Accounting Policies and Estimates

 

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Part I, Item 1.

 

Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes.

 

Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates.

 

Table Of Contents  

34

 
 

Recently Issued Accounting Pronouncements

In April 2015, the FASB issued Accounting Standards Update No. 201503, Interest—Imputation of Interest (Topic 83530): Simplifying the Presentation of Debt Issuance Costs (“ASU 201503”). ASU 201503 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs is not affected by ASU 201503. ASU 201503 is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. The Company has reclassified debt issuance costs from prepaid expenses and other current assets and other assets as a reduction to debt in the condensed consolidated balance sheets.

 

In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 201511, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 201511”), which applies guidance on the subsequent measurement of inventory. ASU 201511 states that an entity should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal and transportation. The guidance excludes inventory measured using last-in, first-out or the retail inventory method. ASU 201511 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company is not planning to early adopt ASU 201511 and is currently evaluating ASU 201511 to determine the potential impact to its condensed consolidated financial statements and related disclosures.

 

Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company’s financial position, results of operations or cash flows.

 

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company extends unsecured credit to its customers in the ordinary course of business but mitigates the associated risks by performing credit checks and actively pursuing past due accounts.

 

The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future write-offs, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible.

 

Inventory

Inventory consist of finished goods purchased, which are valued at the lower of cost or market value, with cost being determined on the first-in, first-out method.  The Company periodically reviews historical sales activity to determine potentially obsolete items and also evaluates the impact of any anticipated changes in future demand.  

 

Valuation of Long-Lived Assets and Identifiable Intangible Assets

The Company reviews for impairment of long-lived assets and certain identifiable intangible assets whenever events or changes in circumstances indicate that the carrying amount of any asset may not be recoverable. In the event of impairment, the asset is written down to its fair market value.

 

Property and Equipment

Property and equipment is stated at cost, less accumulated depreciation and is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5-7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred.

 

Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

 

Table Of Contents  

35

 
 

Intangible Asset - Patent

The Company developed a patent for an installation device used in light fixtures and ceiling fans. Costs incurred for submitting the applications to the United States Patent and Trademark Office for these patents have been capitalized. Patent costs are being amortized using the straight-line method over the related 15 year lives. The Company begins amortizing patent costs once a filing receipt is received stating the patent serial number and filing date from the United States Patent and Trademark Office.

 

The Company incurs certain legal and related costs in connection with patent applications. The Company capitalizes such costs to be amortized over the expected life of the patent to the extent that an economic benefit is anticipated from the resulting patent or alternative future use is available to the Company. The Company also capitalizes legal costs incurred in the defense of the Company’s patents when it is believed that the future economic benefit of the patent will be maintained or increased and a successful defense is probable. Capitalized patent defense costs are amortized over the remaining expected life of the related patent. The Company’s assessment of future economic benefit or a successful defense of its patents involves considerable management judgment, and an unfavorable outcome of litigation could result in a material impairment charge up to the carrying value of these assets.

 

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

· Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
· Level 2 – Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
· Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable – related party, approximate their fair values because of the short maturity of these instruments.

 

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under Level 3.

 

Embedded Conversion Features

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion features.

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.

 

For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

 

Table Of Contents  

36

 
 

Stock-Based Compensation - Employees

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.

 

The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

If the Company is a newly formed corporation or shares of the Company are thinly traded, the use of share prices established in the Company’s most recent private placement memorandum (based on sales to third parties) (“PPM”), or weekly or monthly

price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows:

 

· Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.
· Expected volatility of the entity’s shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.
· Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.
· Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 

Table Of Contents  

37

 
 

Generally, all forms of share-based payments, including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on estimated number of awards that are ultimately expected to vest.

 

The expense resulting from share-based payments is recorded in general and administrative expense in the statements of operations.

 

Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Sub-topic 505-50 of the FASB Accounting Standards Codification (“Sub-topic 505-50”).

 

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. If the Company is a newly formed corporation or shares of the Company are thinly traded the use of share prices established in the Company’s most recent private placement memorandum (“PPM”), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows:

 

· Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder’s expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder’s expected exercise behavior. If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.
· Expected volatility of the entity’s shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.
· Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.
· Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 

Table Of Contents  

38

 
 

Pursuant to ASC paragraph 505-50-25-7, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset.

 

This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.

 

Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a share option and similar instrument that the counterparty has the right to exercise expires unexercised.

 

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

 

Income Tax Provision

From the inception of the Company and through November 6, 2012, the Company was taxed as a pass-through entity (a limited liability company) under the Internal Revenue Code and was not subject to federal and state income taxes; accordingly, no provision had been made.

 

The financial statements reflect the Company’s transactions without adjustment, if any, required for income tax purposes for the period from November 7, 2012 to December 31, 2012. The net loss generated by the Company for the period January 1, 2012 to November 6, 2012 has been excluded from the computation of income taxes.

 

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Consolidated Statements of Operations in the period that includes the enactment date.

 

Table Of Contents  

39

 
 

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

 

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

 

The Company’s tax returns are subject to examination by the federal and state tax authorities for the years ended 2012 through 2015.

 

Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the reporting periods ended December 31, 2015, 2014 and 2013.

 

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

 

Pursuant to Section 850-10-20 the related parties include (i) affiliates of the Company; (ii) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (iii) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (iv) principal owners of the Company; (v) management of the Company; (vi) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (vii) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (i) the nature of the relationship(s) involved; (ii) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (iii) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (iv) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

  

Table Of Contents  

40

 
 

Item 3. Quantitative & Qualitative Disclosures about Market Risks

 

Not applicable.

  

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

As of September 30, 2016 (the “Evaluation Date”), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer, who is also serving as our Principal Financial Officer and Principal Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based upon this evaluation, our Chief Executive Officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the reports that are filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified by the Securities and Exchange Commission’s (the “SEC’s”) rules and forms and that our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management including our Chief Executive Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that the Company’s disclosure controls and procedures will detect or uncover every situation involving the failure of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports.

 

Changes In Internal Controls over Financial Reporting

 

No changes were made in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Table Of Contents  

41

 
 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not currently a party to any pending legal proceedings.

 

Item 1A. Risk Factors

 

As a “smaller reporting company”, we are not required to provide the information required by this Item.

  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The transactions described below were exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), as transactions not involving a public offering.

 

On September 22, 2016, the Company issued 100,000 shares of its common stock to Mark J. Wells, the Company’s President, which vested pursuant to the terms of a Consulting Agreement, dated June 1, 2015, between the Company and Mr. Wells, whereby Mr. Wells provided independent sales consultant services. The services were rendered prior to Mr. Well’s becoming the Company’s President.

 

On September 22, 2016, the Company issued 150,000 shares of its common stock to Mark J. Wells, the Company’s President, pursuant to an Executive Employment Agreement dated August 17, 2016, in exchange for a cash investment made by Mr. Wells of $405,000, for a price per share of $2.70. In connection with the investment, the Company granted purchase options to Mr. Wells to purchase up to 750,000 shares of its common stock exercisable at a price per share of $3.00, which will fully vest on January 1, 2017 and will expire on January 1, 2022.

 

On or about September 22, 2016, the Company entered into a securities subscription agreement with an accredited investor, as defined under Regulation D, Rule 501 of the Securities Act (the “August Subscription Package”), pursuant to which the Company sold (i) 30,000 shares of the Company’s common stock at a purchase price of USD $2.60 per share, (ii) an option to purchase an additional 30,000 shares of the Company’s common stock at a purchase price of USD $2.60 per share within 90 days of the initial closing, (iii) a three-year common stock purchase warrant to purchase up to 60,000 shares of the Company’s common stock (or 120,000 shares if the option in item (ii) is exercised) at an exercise price ranging between USD $3.00 and USD $3.50 per share (depending on the date of exercise), and (iii) a right to subsequently receive warrants to purchase up to 120,000 shares of the Company’s common stock at USD $3.00 per share, which will become issuable upon (a) the Company meeting specified thresholds based on the Company generating earnings before interest, taxes, depreciation and amortization (EBITDA) ranging from $26.9 million to $76.9 million in a fiscal year during the warrant term, (b) completion of a private placement of a minimum of $15,000,000 at pre-money valuation thresholds ranging from $350,000,000 to $1,000,000,000, or (c) the sale of at least fifty percent (50%) of its assets at pre-money valuation thresholds ranging from $350,000,000 to $1,000,000,000 (the “May 2016 Private Placement”). On September 22, 2016, the Company issued 30,000 shares of its common stock to an accredited investor in connection with the foregoing, and received a cash investment of $78,000. Net proceeds were used for the Company’s general working capital. Additional information concerning the use of proceeds from the Stock Offering can be found in the subsection titled “Liquidity and Capital Resources” found in Part I, Item 2 above, which is incorporated by reference into this Part II, Item 2.

 

The August 2016 Preferred Stock Election

 

In July 2016, the Company requested the holders of its Secured Convertible Promissory Notes dated November 26, 2013, May 8, 2014 and June 25, 2014 (each a “Note” and collectively, the “Notes”) to indicate its election (the “August 2016 Election”) to (i) redeem its Note, (ii) convert its Note into the Company’s common stock or (iii) the “Preferred Option” to convert its Note into shares of the Company’s Class A Convertible Preferred Stock (“Preferred Stock”), in each case by August 15, 2016.

 

Prior to the August 2016 Election, several holders of the Notes had previously elected to receive payment in cash, or convert their Notes into shares of the Company’s common stock, but most holders of the Notes had agreed to forbear making an election under their Notes until July 31, 2016, pursuant to one or more forbearance agreements, during such time interest under their respective Notes continued to accrue interest. Because the Company requested that holders make their August 2015 Election by August 15, 2016, the Company extended the period of interest accrual and repaid the interest accrued under such forbearance agreements through August 15, 2016. Pursuant to August 2016 Elections received, the Company thereafter issued shares of the Company’s common stock and Preferred Stock, as applicable, in exchange for the principal balance of the Notes.

Table Of Contents  

42

 
 

For those holders electing the Preferred Option, each holder received shares of the Preferred Stock on a 1 to 1 ratio to the number of shares of the Company’s common stock which were then convertible as unpaid principal under such holder’s respective Note. The Preferred Stock is convertible into shares of the Company’s common stock at the same conversion price as the Notes (i.e., USD $0.25 per share), and pay interest quarterly at a rate of six percent (6%). The Preferred Stock will be convertible upon the election of the holder thereof.

 

Each holder electing the Preferred Option entered into an amendment to its Note, providing that the Note is convertible into the Preferred Stock rather than the Company’s common stock (the “Note Amendment”). In addition, each holder entered into a lock-up agreement, whereby the holder agreed not to offer, sell, contract to sell, pledge, give, donate, transfer or otherwise dispose of (i) the shares of the Company’s common stock it then holds, (ii) the shares of Preferred Stock obtained upon conversion of its Note, and (iii) the shares of the Company’s common stock underlying the Preferred Stock (the “Lock-Up Agreement”). More than a majority of the noteholders of the then-outstanding Notes entered into the Note Amendment or otherwise consented to the Note Amendment, and the Note Amendments, conversion to Preferred Stock and Lock-Up Agreement were entered into effective as of August 15, 2016.

 

As of November 14, 2016, pursuant to all August 2016 Elections, the Company has issued the following:

· 240,000 registered shares of the Company’s common stock, representing $60,000 in outstanding Note principal balance.
· 12,656,935 shares of the Preferred Stock, representing $3,164,234 in outstanding Note principal balance.

 

Based on August 2016 Elections received, the Company will issue an additional 800,000 shares of Preferred Stock, representing $200,000 in Note principal, upon receipt of complete paperwork and original Notes (or in the alternative, a Declaration of Loss of Security) from the respective Note holders. Two individuals holding Notes representing an aggregate principal balance of $100,000 have not responded to the August 2016 Election. All issuances of capital stock in the August 2016 Election have been or will be made only for principal balances due under the Notes, and all interest under the Notes has been or will be paid directly to the Investors.

  

Item 3. Defaults upon Senior Securities

 

None. 

 

Item 5. Other Information

 

On November 7, 2016, the Company’s Board of Directors approved the terms and conditions of an Executive Employment Agreement, dated effective July 1, 2016, between Patricia Barron and the Company (the “COO Agreement”), whereby Ms. Barron will continue to serve as the Chief Operations Officer of the Company.

 

The COO Agreement provides that Ms. Barron will serve for an initial term of two years (the “Initial Term”), which may be renewed by the mutual agreement of Ms. Barron and the Company. Subject to other customary terms and conditions of such agreements, the COO Agreement provides that Ms. Barron will receive a base salary of $120,000 per year. As further consideration, the COO Agreement includes incentive compensation equal to one quarter of one percent of the Company’s net revenue paid in cash on an annual or quarterly basis. Pursuant to the CEO Agreement, if terminated without cause during the Initial Term, the Company shall pay to Ms. Barron (a) an amount calculated by multiplying the monthly salary, at the time of such termination, times the number of months remaining in the Initial Term, and (b) all due but unpaid incentive compensation. For any other termination during the Initial Term, Ms. Barron shall receive payment of salary, at the then current rate, through the date termination is effective and any due but unpaid incentive compensation. The foregoing summary of the COO Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Wells COO Agreement, filed hereto and incorporated herein by reference.

 

Table Of Contents  

43

 
 

Ms. Barron has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K, has no family relationships required to be disclosed pursuant to Item 404(d) of Regulation S-K, and the Company has not entered into or adopted a material compensatory plan to which its principal executive officers participate or are a party.

  

Item 6. Exhibits

 

(b)       Exhibit Index

 

No. Description of Exhibit    
3.1 Articles of Incorporation of the Company, as amended.   (1)
3.2 The Company’s Bylaws   (2)
10.1 The Company’s Certificate of Designation   (5)
10.2 Form of November 2015 Forbearance Agreement.   (3)
10.3 Form of February 2016 Forbearance Agreement.   (4)
10.4 Form of May 2016 Forbearance Agreement.   (5)
10.5 Form of Amendment No. 1 to Secured Convertible Promissory Note   (5)
10.6 Form of Lock-Up Agreement   (5)
10.7 Executive Employment Agreement, dated August 17, 2016, between the Company and Mark J. Wells   (6)
10.8 Executive Employment Agreement, dated September 1, 2016, between the Company and John P. Campi   (6)
10.9 Chairman’s Agreement, dated September 1, 2016 between the Company and Rani Kohen   (6)
10.10 Executive Employment Agreement, dated July 1, 2016, between the Company and Patricia Barron   (1)
10.11 Form of Securities Subscription Agreement, including the terms to issue Volume Warrants, Form of Option Agreement, and form of Common Stock Purchase Warrant used in the August 2016 Private Placement.   (1)
31.1   Certification of Principal Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   (1)
31.2 Certification of Principal Accounting Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   (1)
32.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   (1)
32.2 Certification of Principal Accounting Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   (1)
101 The following materials from the Company’s Quarterly Report on Form 10-Q for the three months ended September 30, 2016 are formatted in XBRL (eXtensible Business Reporting Language):  (i) the Balance Sheets, (ii) the Statements of Operations, (iii) the Statements of Stockholders’ Equity (Deficit), (iv) the Statements of Cash Flows,  and (iv) the Notes to the Financial Statements.   (1)

 

 

 

 

_______________________
(1) Filed herewith.
(2) Incorporated by reference from the Company’s registration statement on Form S-1 filed with the SEC on August 1, 2014 and, declared effective on October 22, 2014.
(3) Incorporated by reference from the Company’s registration statement on Form S-1 filed with the SEC on January 11, 2016, and declared effective on January 20, 2016.
(4) Incorporated by reference to the Company’s Annual Report on Form 10-K filed with the SEC on March 30, 2016.
(5) Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 15, 2016.
(6) Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on November 8, 2016.

 

Table Of Contents  

44

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

SQL TECHNOLOGIES CORP.

 

By: /s/ John P. Campi

John P. Campi

Chief Executive Officer

(Principal Executive Officer)

(Principal Accounting Officer)

Table Of Contents  

45

 

Certificate of Conversion

For

"SAFETY QUICK LIGHT, LLC"

Into

Florida Profit Corporation

 

This Certificate of Conversion and attached Articles of Incorporation are submitted to convert the following "Other Business Entity" into a Florida Profit Corporation in accordance with s. 607.1115, Florida Statutes.

 

1.   The name of the "Other Business Entity" immediately prior to the filing of this Certificate of Conversion is: Safety Quick Light, LLC

 

2.   The "Other Business Entity" is a Limited Liability Company, first organized, formed or incorporated under the laws of Florida on May 14, 2004.

 

3.   If the jurisdiction of the "Other Business Entity" was changed, the state or country under the laws of which it is now organized, formed or incorporated: Not Applicable.

 

4.   The name of the Florida Profit Corporation as set forth in the attached Articles of Incorporation: Safety Quick Lighting & Fans Corp.

 

5.   If not effective on the date of filing, enter the effective date: Date of Filing.

 

Signed this 24th day of October, 2012.

 

  /s/ Rani Kohen

Rani Kohen, Manager

 

 
 

 

ARTICLES OF INCORPORATION

OF

SAFETY QUICK LIGHTING & FANS CORP.

 

The undersigned, desiring to form a corporation (the "Corporation") under the laws of Florida, hereby adopts the following Articles of Incorporation.

 

ARTICLE I

CORPORATE NAME

 

The name of the Corporation is Safety Quick Lighting & Fans Corp.

 

ARTICLE II

PURPOSE

 

The Corporation shall be organized for any and all purposes authorized under the laws of the state of Florida.

 

ARTICLE III

PERIOD OF EXISTENCE

 

The period during which the Corporation shall continue perpetual.

 

ARTICLE IV

SHARES

 

4.1. The capital stock of this corporation shall consist of 500,000,000 shares of common stock, no par value and 20,000,000 shares of preferred stock, no par value.

 

4.2. Preferred Stock. The board of directors is authorized, subject to limitations prescribed by law, to provide for the issuance of shares of Preferred Stock in one or more series, to establish the number of shares to be included in each series, and to fix the designation, powers, including voting rights, if any, preferences, and rights of the shares of each series, and any qualifications, limitations, or restrictions thereof.

 

4.3. Other Powers of the Board of Directors With Respect to Shares.

 

(a) The board of directors may effectuate dividends payable in shares by issuance of shares of any class or series to holders of shares of any other class or series.

 

(b) The board of directors may issue rights and options to acquire shares upon such terms as the board of directors shall determine.

 

ARTICLE V

PLACE OF BUSINESS

 

The initial address of the principal place of business of this corporation in the State of Florida shall be 7695 S.W. 104th Street, Suite 210, Miami, FL 33156. The Board of Directors may at any time move the principal office of this corporation.

 

 

 
 

ARTICLE VI

DIRECTORS AND OFFICERS

 

The business of this corporation shall be managed by its Board of Directors. The number of such directors shall not be less than one (1) and subject to such minimum may be increased or decreased from time to time in the manner provided in the By-Laws.

 

The number or person constituting the initial Board of Directors shall be (11). The Board of Directors shall be elected by the Stockholders of the corporation at such a manner as provided in the By-Laws. The name and addresses of initial Board of Directors and officers are as follows:

 

Rani Kohen   President, Director and Secretary

 

ARTICLE VII

DENIAL OF PREEMPTIVE RIGHTS

 

No share holder shall have any right to acquire share or other securities of the corporation except to the extent to such right may be granted by an amendment to these Articles of Incorporation or by a resolution of the Board of Directors.

 

ARTICLE VIII

AMENDMENT OF BY-LAWS

 

Anything in these Articles of Incorporation, the By-Laws, or the Florida Corporation Act notwithstanding, by-laws not be adopted, modified, amended or repealed by the shareholders of the Corporation except upon the affirmative vote of a simple majority vote of the holders of all the issued and outstanding shares of the corporation entitled to vote thereon.

 

ARTICLE IX

SHAREHOLDERS

 

9.1 Inspection of books. The Board of Directors shall make the reasonable rules to determine at what times and place and under what conditions the books of the shareholders of the Corporation except upon the affirmative vote of a simple majority vote of the holders of all the issued and outstanding shares of the corporation.

 

9.2 Control Share Acquisition. The provisions relating to any control share acquisition as contained in Florida Statutes now, or hereinafter amended, and any successor provision shall not be applied to the Corporation.

 

9.3 Quorum. The holders of shares entitled to one-third of the votes at a meeting of shareholders shall constitute a quorum.

 

9.4 Required Vote. Acts of shareholders shall require the approval of holders of 50.01% of the outstanding votes of shareholders.

 

9.5. Combination. Upon the effectiveness of any "combination," as such term is defined in Section 607.10025(1) of the Florida Business Corporation Act, the authorized shares of the classes or series affected by the combination shall not be reduced or otherwise affected by the percentage by which the issued shares of such class or series were reduced as a result of the combination.

 

ARTICLE X

LIABILITY AND INDEMNIFICATION OF DIRECTORS AND OFFICERS

 

To the fullest extent permitted by law, no director or officer of the Corporation shall be personally liable to the Corporation of its shareholders for damages for breach of any duty owed to the Corporation or its shareholders. In addition, the Corporation shall have the power, in its by-laws or in any resolution of its stockholders or directors, to undertake to indemnify the officers and directors of this corporation against any contingency or peril as may be determined to be in the best interest of this corporation, and ion conjunction therewith, to procure, at this corporation's expense, policies of insurance.

 

 

 
 

ARTICLE XI

CONTRACTS

 

No contract or other transaction between this corporation and any person, firm or corporation shall be affected by the fact that any officer or director of this corporation is such othver party or is, or at some time in the future becomes, an officer, director or partner of such other contracting party, or has now hereafter a direct or indirect interest in such contract.

 

ARTICLE XII

SUBSCRIBER

 

The name and address of the person signing these Articles of Incorporation as subscriber is: Rani Kohen

 

ARTICLE XIII

RESIDENT AGENT

 

The name and address of the initial resident agent of this corporation is:

 

Eric P. Littman

7695 SW 104th Street

Suite 210

Miami, FL 33156

 

IN WITNESS WHEREOF, I have hereunto subscribed to and executed these Articles of Incorporation this on October 24, 2012.

 

/s/ Rani Kohen

Rani Kohen, Subscriber 

 

 
 

 

ARTICLES OF AMENDMENT
TO
ARTICLES OF INCORPORATION
OF

 

Safety Quick Lighting & Fans Corp.

(Name of Corporation as currently filed with the Florida Dept. of State)

 

 

P12000092660

(Document Number of Corporation (if known)

  

Pursuant to the provisions of section 607.1006, Florida Statutes, this Florida Profit Corporation adopts the following amendment(s) to its Articles of Incorporation:

 

A. If amending name, enter the new name of the corporation:

 

SQL Technologies Corp.

 

 

B.    Enter new principal office address, if applicable:  

4400 North Point Parkway, Suite 154

Alpharetta, GA 300222

C.    Enter new mailing address, if applicable:  

4400 North Point Parkway, Suite 154

Alpharetta, GA 300222

   
     

D.    If amending the registered agent and/or registered office address in Florida, enter the name of the new registered agent and/or the new registered office address:

 

N/A

  

New Registered Agent's Signature., if changing Registered Agent:

I hereby accept the appointment as registered agent. I am familiar with and accept the obligations of the position.

 

 

N/A

Signature of New Registered Agent, if changing

 

 

If amending the Officers and/or Directors, enter the title and name of each officer/director being removed and title, name, and address of each Officer and/or Director being added:

 

Please note the officer/director title by the first letter of the office title: P = President; V= Vice President; T= Treasurer; S= Secretary; D= Director; TR= Trustee; C = Chairman or Clerk; CEO = Chief Executive Officer; CFO = Chief Financial Officer.

  

 

 
 

  Type of Action Title Name Address
  (Check One)      
         
1)    X Change D C Rani Kohen 4400 North Point Parkway
   Add     Suite 154
   Remove     Alpharetta, GA 300222
         
         
2) Change P CEO John P. Campi 4400 North Point Parkway
    X Add   Suite 154  
   Remove     Alpharetta, GA 300222

 

E. If amending or adding additional Articles, enter change(s) here :

 

 

See attached CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES OF

SERIES A PREFERRED STOCK.

 

 

F. If an amendment provides for an exchange, reclassification, or cancellation of issued shares,

provisions for implementing the amendment if not contained in the amendment itself:

 

N/A

  

The date of each amendment(s) adoption: June 8, 2016 , if other than the date this document was signed.

 

Effective date if applicable: August 12, 2016

 

Adoption of Amendment(s) :

 

■ The amendment(s) was/were adopted by the shareholders. The number of votes cast for the amendment(s) by the shareholders was/were sufficient for approval.

 

■ The amendment(s) was/were approved by the shareholders through voting groups.

 

■ The amendment(s) was/were adopted by the board of directors without shareholder action and shareholder action was not required.

 

■ The amendment(s) was/were adopted by the incorporators without shareholder action and shareholder action was not required.

 

Dated: June 27, 2016

 

Signature: /s/ John P. Campi

John P. Campi

President and CEO

 

 
 

 

CERTIFICATE OF DESIGNATION

OF RIGHTS, PREFERENCES AND PRIVILEGES OF

SERIES A PREFERRED STOCK

OF

SAFETY QUICK LIGHTING & FANS CORP.

 

Pursuant to Sections 607.0601 and 607.0602 of the Florida Statutes, Safety Quick Lighting & Fans Corp., a corporation organized and existing under laws of the State of Florida (the “ Company ”), does hereby submit the following:

 

WHEREAS , pursuant to the Company’s Articles of Incorporation, dated November 16, 2012, the Company has 500,000,000 shares of common stock, no par value per share (“ Common Stock ”), and 20,000,000 shares of preferred stock, no par value (the “ Preferred Stock ”), outstanding, and the Company’s Board of Directors is authorized to issue and establish one or more series of the Preferred Stock and to fix the designation, rights, preferences, powers, restrictions and limitations thereof;

 

WHEREAS , no series of the Preferred Stock has been designated, and no shares of Preferred Stock have heretofore been issued; and

 

WHEREAS , it is the desire of the Company, its Board of Directors, and a majority of its shareholders to establish and fix the number of shares to be included in a new series of Preferred Stock and the designation, rights, preferences and limitations of the shares of such new series.

 

NOW, THEREFORE, BE IT RESOLVED , that, pursuant to the authority conferred upon as of June 8, 2016, the Company’s Board of Directors and an absolute majority of the Company’s voting shareholders of record as of June 1, 2016 do hereby provide for the issuance of a series of Preferred Stock and to establish and fix and herein state and express, by this Certificate of Designation (the “ Certificate of Designation ”), the designation, rights, preferences, powers, restrictions and limitations of such series of Preferred Stock as follows:

 

  1. DESIGNATION AND AMOUNT. There shall be a series of Preferred Stock that shall be designated as “Series A Convertible Preferred Stock” (the " Series A Preferred Stock ") and the number of shares (the “ Shares ”) constituting such series shall be 20,000,000. The rights, preferences, powers, restrictions and limitations of the Series A Preferred Stock shall be as set forth herein.

 

  2. ISSUANCE OF SHARES. Each Share of Series A Preferred Stock shall be issuable only to the holders of the Company’s Secured Convertible Promissory Notes issued on November 26, 2013, May 8, 2014 or June 25, 2014 (the “ Notes ”) who have amended their Notes outstanding to be convertible into the Series A Preferred Stock, pursuant to a written election by such holder, at a conversion price of USD $0.25 per Share based on the original purchase price of the one or more Note(s) issued to the holder thereof, plus any accrued but unpaid interest or amounts due in connection therewith (in the aggregate, the “ Note Balance ”).

 

  3. INTEREST .

 

(a)    Interest. From and after the date of issuance of any Share, cumulative interest on such Share shall accrue, whether or not declared by the Board and whether or not there are funds legally available for the payment of interest, on a monthly basis at the rate of 6% per annum on the sum of the Liquidation Value thereof plus all unpaid accrued and accumulated interest thereon. All accrued interest on any Share shall be paid in cash to the holder thereof quarterly, with the first such payment due beginning on September 30, 2016 and payable on the last day of the month of each calendar quarter thereafter.

 

 

 
 

(b)   Priority . All accrued and accumulated interest on the Shares shall be prior and in preference to any dividend or interest on any Junior Securities and shall be fully declared and paid before any dividends are declared and paid, or any other distributions or redemptions are made, on any Junior Securities, other than to (i) declare or pay any dividend or distribution payable on the Common Stock in shares of Common Stock or (ii) repurchase Common Stock held by employees or consultants of the Corporation upon termination of their employment or services pursuant to agreements providing for such repurchase.

 

  4. RANK AND LIQUIDATION.

 

(a)    Rank . With respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, all Shares of the Series A Preferred Stock shall rank senior to all Common Stock and any other class of securities that is specifically designated as junior to the Series A Preferred Stock (“ Junior Securities ”).

 

(b)   Liquidation . In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Shares of Series A Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its shareholders, before any payment shall be made to the holders of Junior Securities by reason of their ownership thereof, an amount in cash equal to the aggregate Liquidation Value (as defined below), plus all unpaid accrued and accumulated dividends on all such Shares (whether or not declared). In the event that the funds are not sufficient to pay out the full Liquidation Value to all holders of Shares of Series A Preferred Stock, the Liquidation Value shall be paid to such holders pro rata based each holder’s Liquidation Value relative to the Liquidation Value of all holders of Shares of Series A Preferred Stock.

 

(c)    “ Liquidation Value ” means, with respect to a holder of Shares, the aggregate value of the Note Balance converted by such holder into Shares of Series A Preferred Stock.

 

  5. CONVERSION RIGHTS.

 

(a)    Elective Conversion . Each Share of Series A Preferred Stock shall be convertible at any time by the holder thereof into one (1) share of Common Stock.

 

(b)   Effect of Conversion . All Shares of Series A Preferred Stock converted as provided herein shall no longer be deemed issued and outstanding as of the effective time of the applicable conversion, and all rights with respect to such Shares shall immediately cease and terminate as of such time, other than the right of the holder to receive shares of Common Stock in exchange therefor.

 

  6. VOTING RIGHTS. Each Share of Series A Preferred Stock shall have no right to vote on any matter to be submitted for a vote to shareholders of the Company.

 

  7. ADJUSTMENT. In the event that the Company shall, at any time after the issuance of any Share of Series A Preferred Stock, (a) declare any dividend on Common Stock payable in shares of Common Stock, (b) subdivide or effectuate any stock-split of the outstanding Common Stock or (c) combine or recapitalize the outstanding Common Stock into a different number of shares, then in each such case the Company shall simultaneously effect a proportional adjustment to the number of outstanding Shares of Series A Preferred Stock.

 

  8. CONSOLIDATION, MERGER, ETC. In the event the Company enters into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case the Shares of Series A Preferred Stock shall at the same time be similarly exchanged or changed into preferred stock of the surviving Company with the same rights and preferences as the Series A Preferred Stock.

 

 

 
 

  9. WAIVER. Any of the rights, powers, preferences and other terms of the Series A Preferred Stock set forth herein may be waived on behalf of a holder of Shares in its sole discretion.

 

  10. REPURCHASE AND PUT OPTION.

 

(a)    Repurchase Notice . The Company may, at any time after the issuance of any Share of Series A Preferred Stock, by providing 30 day’s prior written notice to all holders of the Shares (a “ Repurchase Notice ”), repurchase some or all of the Shares outstanding from the holders thereof at a purchase price of USD $3.50 per Share (the “ Repurchase Price ”). Any Repurchase Notice for less than the full number of Shares issued and outstanding shall be for purchase pro rata , based each holder’s number of Shares outstanding relative to the aggregate number of Shares outstanding.

 

(b)   Repurchase Period . Each holder of Shares must sell to the Company the number of Shares specified in a Repurchase Notice on the date set forth therein, such date being no less than thirty (30) days following the date of such Repurchase Notice (the “ Repurchase Period ”), except where the Shares subject to the Repurchase Notice are converted, by election or automatically, into Common Stock prior to the end of the Repurchase Period and such holder thereafter no longer holds Shares of Series A Preferred Stock.

 

(c)    Put Option . Any holder of Shares may, at any time after the issuance of any Share of Series A Preferred Stock, by providing a written request to the Company, require the Company to purchase some or all such holder’s Shares outstanding at a purchase price of USD $0.25 per Share, and the Company shall promptly purchase the number of Shares so specified and owned by the holder thereof.

 

(d)   Effect of Repurchase . All Shares of Series A Preferred Stock repurchased or purchased by the Company as provided in this Section 10 shall no longer be deemed issued and outstanding as of the effective time of the applicable repurchase or purchase, and all rights with respect to such Shares shall immediately cease and terminate as of such time.

 

  11. ASSIGNMENT. Each holder of Shares of Series A Preferred Stock shall be entitled to transfer some or all of its Shares to one or more affiliated partnerships or funds managed by it or any of such holder’s respective directors, officers or partners; provided, however, that any such transferee agrees in writing to be subject to the identical terms of any conversion and/or related agreements entered into by the holder thereof in connection with the issuance of the transferred Shares.

 

  12. AMENDMENT. No provision of this Certificate of Designation may be amended, modified or waived except by an instrument in writing executed by the Company and the holders of a majority of Shares of Series A Preferred Stock, and any such written amendment, modification or waiver will be binding upon the Company and each holder of Series A Preferred Stock; provided, that no such action shall change or waive (a) the definition of Liquidation Value, (b) the rate at which or the manner in which interest on the Series A Preferred Stock accrues or accumulates, (c) the Repurchase Price, or (d) this Section 12, without the prior written consent of holders of at least seventy-five (75%) of all outstanding Shares of Series A Preferred Stock.

 

IN WITNESS WHEREOF , this Certificate of Designation is executed on behalf of the Company by its Chief Executive Officer on July 27, 2016.

 

 

/s/ John P. Campi

John P. Campi, Chief Executive Officer

 

 

 

 

 

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (the “Agreement”) dated July 1, 2016 by and between Safety Quick Lighting & Fans Corp., a corporation duly organized under the laws of the state of Florida (together with its subsidiaries and predecessor companies hereinafter referred to as the “Company”) and Patricia Barron, a resident of the state of Georgia (hereinafter referred to as the “Executive”).

NOW, THEREFORE, the parties hereto agree as follows:

1.                                 Employment. Company hereby agrees to employ Executive as its Chief Operations Officer and Executive hereby accepts such employment in accordance with the terms of this Agreement, and the terms of employment applicable to regular employees of Company.

2.                                 Duties of Executive. The duties of Executive shall include the performance of all of the duties and projects as may be assigned by the Chairman of the Board, the Chief Executive Officer and the Board of Directors of the Company. Executive shall perform all duties in a professional, ethical and businesslike manner. Executive shall be required to devote such time to the affairs of the Company as shall be necessary to manage such affairs. Executive shall perform such duties principally from the Company’s offices in Alpharetta, Georgia and/or Fort Lauderdale, Florida, subject to such reasonable travel as may be required. With the exception of those listed on Exhibit A, during the term of this Agreement, Executive’s direct or indirect engagement in any other businesses or concerns in any capacity, either with or without compensation will require prior written consent of Company.

3.                                 Compensation. Executive shall be paid compensation during the term of this Agreement as follows:

a)                  A base salary of one hundred and twenty thousand dollars ($120,000) per year ($10,000 per month), payable in installments according to the Company’s regular payroll schedule. The base salary shall be reviewed at the end of each year of service and adjusted by the Company’s Compensation Committee of the Company’s Board of Directors, at its sole discretion.

b)                  Incentive compensation equal to one quarter of one percent (0.0025) of Net Revenue (as defined herein) paid in cash on an annual or quarterly basis pursuant to the Company’s annual audit conducted by its independent auditor.

Net Revenue -shall mean total sales less returns and discounts.

4.       Benefits.

 

1

 
 

a)                  Vacation. Executive shall be entitled to three (3) weeks paid vacation days each year.

b)                  Sick Leave. Executive shall be entitled to sick leave and emergency leave according to the regular policies and procedures of Company. Additional sick leave or emergency leave over and above paid leave provided by the Company, if any, shall be unpaid and shall be granted at the discretion of the board of directors.

c)                  Medical and Group Life Insurance. In the event the Company offers such a plan, Company agrees to include Executive, at the Executive’s option, in a group medical and hospital insurance plan the Company may offer during this Agreement. Executive shall be responsible for payment of any federal or state income tax imposed upon these benefits. The offering of a group medical and hospital insurance plan is at the discretion of the Company and NOT a condition of employment by the Executive.

d)                  Expense Reimbursement. Executive shall be entitled to reimbursement for all reasonable expenses, including travel and entertainment, incurred by Executive in the performance of Executive’s duties. Executive will maintain records and written receipts as required by the Company policy and reasonably requested by the Company’s Board of Directors to substantiate such expenses.

5.                Initial Term. The term of this Agreement shall commence on July 1, 2016 and shall continue in effect for a period of two (2) years (the “Initial Tern”). Following the expiration of the Initial Tern, the Agreement shall be renewed upon the mutual agreement of Executive and Company.

6.                Termination

a)       The Company may terminate Executive for cause. Cause shall be defined as:

(i)               An act of fraud, embezzlement, theft or neglect of or refusal to substantially perform the duties of Executive’s employment which is materially injurious to the financial condition or business reputation of the Company;

(ii)             A material violation of this Agreement by Executive, which is not cured within thirty (30) days after written notice thereof;

(iii)           Executive’s death, disability or incapacity.

b)       This Agreement is an “At Will” employment agreement and nothing in the Company’s policies, actions, or this document shall be construed to alter the “At Will” nature of Executive’s status with the Company, and Employee understands that the Company may terminate Executive’s employment at any time for any reason or for no reason, provided it is not terminated in violation of state or federal law. If, however,

 

2

 
 

Executive is terminated without cause, Company shall pay to Executive an amount calculated by multiplying the Executive’s monthly salary, at the time of such termination, times the number of months remaining in the Initial Term (as an example, if Executive were terminated at the end of the sixth month of employment, Executive would be entitled to receive a one-lump payment in cash equal to the remaining six months base compensation of the Initial Term at the time of termination). In addition, if Executive is terminated without cause, Executive’s Sign-on Bonus shares shall immediately vest. In the event of such termination, Executive shall be entitled to any due but unpaid Incentive Compensation then in effect.

c)                  This Agreement and Executive’s employment may be terminated by the Company’s Board of Directors at its discretion at any time after the Initial Term, provided that in such case, Executive shall be paid one (1) month of Executive’s then applicable annual base salary for every year of employment in the Company. In the event of such a discretionary termination, Executive shall be entitled to any due but unpaid Incentive Compensation then in effect.

d)                  This Agreement may be terminated by Executive at Executive’s discretion by providing at least thirty (30) days prior written notice to Company. In the event of termination by Executive pursuant to this subsection, Company may immediately relieve Executive of all duties and immediately terminate this Agreement, provided that Company shall pay Executive at the then applicable base salary rate and Executive shall be entitled to any due but unpaid Incentive Compensation to the termination date included in Executive’s original termination notice.

e)                  In the event Company is acquired, or is the non-surviving entity in a merger, or sells all or substantially all of its assets, this Agreement, all of the provisions and rights provided herein shall survive. The Company shall use its best efforts to ensure that the transferee or surviving company is bound by the provisions of this Agreement and all shares grants will vest immediately.

7.       Notices. Any notice required by this Agreement or given in connection with it, shall be in writing and shall be given to the appropriate party by personal delivery or by certified mail, postage prepaid, or recognized overnight delivery services;

If to Company:

Safety Quick Lighting & Fans Corp.
4400 North Point Parkway, Suite 154
Alpharetta, GA 30305

If to Executive:

[REDACTED]

 

3

 
 

8.                Final Agreement. This Agreement supersedes all prior understandings or agreements on the subject matter hereof. This Agreement may be modified only in writing and that which is duly executed by both parties.

9.                Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the state of Florida.

10.            Headings. Headings used in this Agreement are provided for convenience only and shall not be used to construe meaning or intent.

11.            No Assignment. Neither this Agreement nor any or interest in this Agreement may be assigned by Executive without the prior express written approval of Company, which may be withheld by Company at Company’s absolute and sole discretion.

12.            Severability. If any term of this Agreement is held by a court of competent jurisdiction to be invalid or unenforceable, then this Agreement, including all of the remaining terms, shall remain in full force and effect as if such invalid or unenforceable term had never been included.

13.            Arbitration. The parties agree that they shall use their best efforts to amicably resolve any dispute arising out of or relating to this Agreement. Any controversy, claim or dispute that cannot be so resolved shall be settled by final binding arbitration in accordance with the rules of the American Arbitration Association and judgment upon the award rendered by the arbitrator or arbitrators may be entered in any court having jurisdiction thereof. Any such arbitration shall be conducted in the state of Florida, or such other place as may be mutually agreed upon by the parties. Within fifteen (15) days after the commencement of the arbitration, each party shall select one person to act as arbitrator, and the two arbitrators so selected shall select a third arbitrator within ten (10) days of their appointment. Each party shall bear its own costs and expenses and an equal share of the arbitrator’s expenses and administrative fees of arbitration.

 

******** Signature Page Follows ********

 

 

4

 
 

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of July 1, 2016.

EXECUTIVE 

 

/s/ Patricia Barron

Patricia Barron

 

 

SAFETY QUICK LIGHTING & FANS COR

 

/s/ John P. Campi

John P. Campi, President & CEO

 

/s/ Rani Kohen

Rani Kohen, Chairman

 

5

 

 

 

 

 

SECURITIES SUBSCRIPTION AGREEMENT

 

 

As of _______, 2016

SQL Technologies Corp.

4400 North Point Parkway, Suite 154

Alpharetta, GA 30022

 

Investors:

 

1.1. Subscription; Payment .

 

(a)       The undersigned subscriber (the “ Subscriber ”) hereby irrevocably subscribes for and agrees to purchase from SQL Technologies Corp., a Florida corporation (the “ Company ”), (i) up to ______ shares of the Company’s common stock, no par value per share (“ Common Stock ”), at USD $2.60 per share as set forth on the signature page hereto, (ii) a 90-day option to purchase up to the same number of shares of Common Stock purchased by the Subscriber in the Closing, at an exercise price of $2.60 per share, the form of which is attached as Exhibit A hereto, (iii) three-year warrants to purchase shares of Common Stock at an exercise price of USD $3.00 to $3.50 per share, depending on the date of exercise, the form of which is attached as Exhibit B hereto, and (iv) the right to obtain Volume Warrants (as defined below), upon the terms and conditions set forth in Section 5 hereto (collectively, the “ Securities ”), pursuant to the terms set forth in the Confidential Term Sheet and this Securities Subscription Agreement (this “ Transaction ”). This Securities Subscription Agreement, which incorporates by reference all exhibits and schedules attached to the Investor Package issued in connection with the Investor Package dated August 2016, shall be hereinafter referred to as the “ Subscription Agreement ”; together with such exhibits and schedules attached hereto, the “ Sale Documents ”. Any capitalized term not defined herein shall have the meaning of such term as has been set forth in the Sale Documents. The minimum investment per Subscriber shall be $25,000, which may be waived by the Company in its sole discretion. All amounts in this Subscription Agreement are expressed in US Dollars.

 

This subscription for the Securities is based upon the information provided in the Sale Documents and upon the Subscriber’s own investigation as to the merits and risks of this investment. The Subscriber shall deliver herewith duly executed copies of the signature pages to this Subscription Agreement and the Accredited Investor Questionnaire & Form W-9 (the “ Investor Questionnaire ”) provided by the Company to the Subscriber.

 

It is currently anticipated that the closing of the Transaction will take place on or around August ___, 2016 (the “ Closing ” and the date upon which a Closing occurs, the “ Closing Date ”), unless otherwise extended or modified by the Company in its sole discretion.

 

(b)       Subject to the terms and conditions hereinafter set forth, the Subscriber hereby subscribes for and agrees to purchase from the Company the number of shares of Common Stock set forth on the signature page hereto (the “ Shares ”), at a purchase price of Two and Six Tenths US Dollars (USD $2.60) per share of Common Stock (the “ Purchase Price ”). When this Subscription Agreement is accepted and executed by the Company, the Company agrees to issue the Securities to the Subscriber. The Purchase Price is payable by wire transfer to Citibank, New York, NY for SQL Technologies Corp. for pursuant to the following wire instructions.

 

WIRING INSTRUCTIONS

[REDACTED]

 

Provided that (i) the Subscriber has satisfied all conditions set forth herein and (ii) the Company has accepted and executed this Subscription Agreement, the Securities purchased by the Subscriber will be delivered to the Subscriber by the Company promptly following the Closing Date. In the event that a Closing does not occur, Subscriber’s funds will be returned by the Company to the Subscriber.

 

 

1

 
 

2.                  Subscriber Representations, Warranties and Agreements . The Subscriber hereby acknowledges, represents and warrants as follows (with the understanding that the Company will rely on such representations and warranties in determining, among other matters, the suitability of this investment for the Subscriber in order to comply with federal and state securities laws):

 

(a)       In connection with this subscription, the Subscriber has read this Subscription Agreement. The Subscriber acknowledges that this Subscription Agreement is not intended to set forth all of the information which might be deemed pertinent by an investor who is considering an investment in the Securities. It is the responsibility of the Subscriber (i) to determine what additional information he desires to obtain in evaluating this investment, and (ii) to obtain such information from the Company.

 

(b)        This Transaction is limited to persons who are “accredited investors,” as that term is defined in RULE 501 OF Regulation D under the 1933, as amended (the “ Act ”), and who have the financial means and the business, financial and investment experience and acumen to conduct an investigation as to, and to evaluate, the merits and risks of this investment. The Subscriber hereby represents that he has read, is familiar with and understands Rule 501 of Regulation D under the Act. The Subscriber is an “accredited investor” as defined in Rule 501(a) of Regulation D UNDER THE ACT.

 

(c)       The Subscriber has had full access to all the information which the Subscriber (or the Subscriber’s advisor(s)) considers necessary or appropriate to make an informed decision with respect to the Subscriber’s investment in the Securities. The Subscriber acknowledges that the Company has made available to the Subscriber and the Subscriber’s advisors the opportunity to examine and copy any contract, matter or information which the Subscriber considers relevant or appropriate in connection with this investment and to ask questions and receive answers relating to any such matters including, without limitation, the financial condition, management, employees, business, obligation, corporate books and records, budgets, business plans of and other matters relevant to the Company. To the extent the Subscriber has not sought information regarding any particular matter, the Subscriber represents that he or she had and has no interest in doing so and that such matters are not material to the Subscriber in connection with this investment. The Subscriber has accepted the responsibility for conducting the Subscriber’s own investigation and obtaining for itself such information as to the foregoing and all other subjects as the Subscriber deems relevant or appropriate in connection with this investment. The Subscriber is not relying on any representation or warranty other than that contained herein. The Subscriber acknowledges that no representation regarding projected revenues or a projected rate of return has been made to it by any party.

 

(d)       The Subscriber understands that this Transaction has not been registered under the Act, in reliance on an exemption for private offerings provided pursuant to Section 4(2) of the Act and that, as a result, the Securities will be “restricted securities” as that term is defined in Rule 144 under the Act and, accordingly, under Rule 144 as currently in effect, that the Securities must be held for at least one (1) year after the investment has been made (or indefinitely if the Subscriber is deemed an “affiliate” within the meaning of such rule) unless the Securities are subsequently registered under the Act and qualified under any other applicable securities law or exemptions from such registration. The Subscriber further understands that this Transaction has not been qualified or registered under any foreign or state securities laws in reliance upon the representations made and information furnished by the Subscriber herein and any other documents delivered by the Subscriber in connection with this Subscription Agreement; that this Transaction has not been reviewed by the U.S. Securities and Exchange Commission or by any foreign or state securities authorities; that the Subscriber’s rights to transfer the Securities will be restricted, which includes restrictions against transfers unless the transfer is not in violation of the Act and applicable state securities laws (including investor suitability standards); and that the Company may in its sole discretion require the Subscriber to provide at Subscriber’s own expense an opinion of its counsel to the effect that any proposed transfer is not in violation of the Act or any state securities laws.

 

 

2

 
 

(e)       The Subscriber is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D under the 1933 Act. The Subscriber has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the purchase of the Common Stock. The Subscriber is not registered as a broker or dealer under Section 15(a) of the Securities Exchange Act of 1934, as amended, affiliated with any broker or dealer registered under Section 15(a) of the Securities Exchange Act of 1934, as amended, or a member of the Financial Industry Regulatory Authority.

 

(f)       This Subscription Agreement and the Sale Documents have been duly and validly authorized, executed and delivered on behalf of the Subscriber and is a valid and binding agreement of the Subscriber enforceable against the Subscriber in accordance with their terms, subject as to enforceability to general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies. The Subscriber has the requisite corporate power and authority to enter into and perform its obligations under this Subscription Agreement and the Sale Documents, and each other agreement entered into by the parties hereto, in connection with the transactions contemplated by this Subscription Agreement.

 

(g)       The execution, delivery and performance of this Subscription Agreement and the Sale Documents by the Subscriber and the consummation by the Subscriber of the transactions contemplated hereby and thereby will not (i) result in a violation of the articles of incorporation, by-laws or other documents of organization of the Subscriber, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Subscriber is bound, or (iii) result in a violation of any law, rule, regulation or decree applicable to the Subscriber.

 

(h)       The Subscriber understands that the Securities are being offered and sold in reliance on a transactional exemption from the registration requirements of federal and state securities laws and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Subscriber set forth herein in order to determine the applicability of such exemptions and the suitability of the Subscriber to acquire the Securities.

 

(i)       The Subscriber acknowledges that there will be no market for the Securities and that the Subscriber may not be able to sell or dispose of them; the Subscriber has liquid assets sufficient to assure that the purchase price of the Securities will cause no undue financial difficulties and that, after purchasing the Securities the Subscriber will be able to provide for any foreseeable current needs and possible personal contingencies; the Subscriber is able to bear the risk of illiquidity and the risk of a complete loss of this investment.

 

(j)       The information in any documents delivered by the Subscriber in connection with this subscription, including, but not limited to the Investor Questionnaire, is true, correct and complete in all respects as of the date hereof. The Subscriber agrees promptly to notify the Company in writing of any change in such information after the date hereof.

 

(k)       This Transaction and sale of the Securities to the Subscriber were not made through any advertisement in printed media of general and regular paid circulation, radio or television or any other form of advertisement, or as part of a general solicitation.

 

 

3

 
 

(l)       The Subscriber recognizes that an investment in the Securities involves significant risks, which risks could give rise to the loss of the Subscriber’s entire investment in such securities.

 

(m)       The Subscriber is purchasing the Securities for the Subscriber’s own account, with the intention of holding the Securities, with no present intention of dividing or allowing others to participate in this investment or of reselling or otherwise participating, directly or indirectly, in a distribution of the Securities, and shall not make any sale, transfer, or pledge thereof without registration under the Act and any applicable securities laws of any state or unless an exemption from registration is available under those laws.

 

(n)       The Subscriber represents that the Subscriber, if an individual, has adequate means of providing for his or her current needs and personal and family contingencies and has no need for liquidity in this investment in the Securities. The Subscriber has no reason to anticipate any material change in his or her personal financial condition for the foreseeable future.

 

(o)       The Subscriber is financially able to bear the economic risk of this investment, including the ability to hold the Securities indefinitely or to afford a complete loss of the Subscriber’s investment in the Securities.

 

(p)        If the Subscriber is a partnership, corporation, trust, or other entity, (i) the Subscriber has enclosed with this Subscription Agreement appropriate evidence of the authority of the individual executing this Subscription Agreement to act on its behalf (e.g., if a trust, a certified copy of the trust agreement; if a corporation, a certified corporate resolution authorizing the signature and a certified copy of the certificate of incorporation; or if a partnership, a certified copy of the partnership agreement), (ii) the Subscriber represents and warrants that it was not organized or reorganized for the specific purpose of acquiring the Securities, (iii) the Subscriber has the full power and authority to execute this Subscription Agreement on behalf of such entity and to make the representations and warranties made herein on its behalf, and (iv) this investment in the Company has been affirmatively authorized, if required, by the governing board of such entity and is not prohibited by the governing documents of the entity.

 

3.                  Representations and Warrants of the Company . As a material inducement of the Subscriber to enter into this Subscription Agreement and subscribe for the Securities, the Company represents and warrants to the Subscriber, as of the date hereof, as follows:

 

(a)        Organization and Standing . The Company is a duly organized corporation, validly existing and in good standing under the laws of the State of Florida, has full power to carry on its business as and where such business is now being conducted and to own, lease and operate the properties and assets now owned or operated by it and is duly qualified to do business and is in good standing in each jurisdiction where the conduct of its business or the ownership of its properties requires such qualification except where the failure to be so qualified would not have a Material Adverse Effect. “ Material Adverse Effect ” means any circumstance, change in, or effect on the Company that, individually or in the aggregate with any other similar circumstances, changes in, or effects on, the Company taken as a whole: (i) is, or is reasonably expected to be, materially adverse to the business, operations, assets, liabilities, employee relationships, customer or supplier relationships, prospects, results of operations or the condition (financial or otherwise) of the Company taken as a whole, or (ii) is reasonably expected to adversely affect the ability of the Company to operate or conduct the Company’s business in the manner in which it is currently operated or conducted or proposed to be operated or conducted by the Company.

 

(b)        Authority . The execution, delivery and performance of this Subscription Agreement and the other Sale Documents by the Company and the consummation of the transactions contemplated hereby and thereby have been duly authorized by the Board of Directors of the Company.

 

 

4

 
 

(c)        No Conflict . The execution, delivery and performance of this Subscription Agreement and the other Sale Documents, and the consummation of the transactions contemplated hereby and thereby do not (i) violate or conflict with the Company’s Articles of Incorporation, By-laws or other organizational documents, (ii) conflict with or result (with the lapse of time or giving of notice or both) in a material breach or default under any material agreement or instrument to which the Company is a party or by which the Company is otherwise bound, or (iii) violate any order, judgment, law, statute, rule or regulation applicable to the Company, except where such violation, conflict or breach would not have a Material Adverse Effect. This Subscription Agreement and the Sale Documents when executed by the Company will be a legal, valid and binding obligation of the Company enforceable in accordance with its terms (except as may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws and equitable principles relating to or limiting creditors’ rights generally).

 

(d)        Authorization . Issuance of the Securities to the Subscriber has been duly authorized by all appropriate corporate actions of the Company.

 

(e)        Litigation and Other Proceedings . There are no actions, suits, proceedings or investigations pending or, to the knowledge of the Company, threatened against the Company at law or in equity before or by any court or federal, state, municipal or their governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign which could materially adversely affect the Company. The Company is not subject to any continuing order, writ, injunction or decree of any court or agency against it which would have a material adverse effect on the Company.

 

(f)        Use of Proceeds . The proceeds of this Transaction and sale of the Securities, net of payment of placement expenses, will be used by the Company for working capital and other general corporate purposes subject to the restrictions set forth in the Securities and on Schedule 1 of the Investor Package.

 

(g)        Consents/Approvals . No consents, filings (other than federal and state securities filings relating to the issuance of the Securities pursuant to applicable exemptions from registration, which the Company hereby undertakes to make in a timely fashion), authorizations or other actions of any governmental authority are required to be obtained or made by the Company for the Company’s execution, delivery and performance of this Subscription Agreement which have not already been obtained or made or will be made in a timely manner following the Closing.

 

(h)        No Commissions . The Company has not incurred any obligation for any finder’s, broker’s or agent’s fees or commissions in connection with the transaction contemplated hereby.

 

(i)        Capitalization . A capitalization table illustrating the authorized and the outstanding capital stock of the Company as of the date of the Investor Package is attached as Schedule 2 of the Investor Package. All of such outstanding shares have been, or upon issuance will be, validly issued, fully paid and nonassessable. As of the date of the Investor Package, except as disclosed in Schedule 2.2 of the Investor Package or pursuant to any other issuance of Securities in this Transaction, (i) no shares of the Company’s capital stock are subject to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company; (ii) there are no outstanding debt securities; (iii) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its subsidiaries; (iv) there are no outstanding securities of the Company or any of its subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any of its subsidiaries is or may become bound to redeem a security of the Company or any of its subsidiaries; and (v) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities. The Company will furnish to the Subscriber upon request, true and correct copies of the Company’s Articles of Incorporation, as amended and as in effect on the date hereof (the “ Articles of Incorporation ”), and the Company’s By-laws, as in effect on the date hereof (the “ By-laws ”) attached hereto as Schedule 5 of the Investor Package, and the terms of all securities convertible or exchangeable into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto. Schedule 2.1 of the Investor Package hereto also lists all outstanding debt of the Company for borrowed money.

 

 

5

 
 

(j)        Employee Relations . Neither the Company nor any of its subsidiaries is involved in any labor dispute nor, to the knowledge of the Company or any of its subsidiaries, is any such dispute threatened, the effect of which would be reasonably likely to result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries is a party to a collective bargaining agreement.

 

(k)        Intellectual Property Rights . The Company and its subsidiaries own or possess adequate rights or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted. The Company and its subsidiaries do not have any knowledge of any infringement by the Company or its subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade secret or other similar rights of others, or of any such development of similar or identical trade secrets or technical information by others and, except as set forth on Schedule 3 of the Investor Package, there is no claim, action or proceeding being made or brought against, or to the Company’s knowledge, being threatened against, the Company or its subsidiaries regarding trademarks, trade name rights, patents, patent rights, inventions, copyrights, licenses, service names, service marks, service mark registrations, trade secrets or other infringement.

 

(l)        Environmental Laws . The Company and its subsidiaries (i) are to the Company’s knowledge in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“ Environmental Laws ”), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses, and (iii) are in compliance with all terms and conditions of any such permit, license or approval where such noncompliance or failure to receive permits, licenses or approvals referred to in clauses (i), (ii) or (iii) above would be reasonably likely to result in a Material Adverse Effect.

 

(m)        Disclosure . No representation or warranty by the Company in this Subscription Agreement, the other Sale Documents, nor in any certificate, schedule or exhibit delivered or to be delivered pursuant to this Subscription Agreement or the other Sale Documents contains or will contain any untrue statement of material fact or omits or will omit to state a material fact necessary to make the statements contained herein or therein not misleading. To the knowledge of the Company and its subsidiaries at the time of the execution of this Subscription Agreement, there is no information concerning the Company and its subsidiaries or their respective businesses which has not heretofore been disclosed to the Subscribers that would have a Material Adverse Effect.

 

(n)        Title . The Company and its subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 2.1 of the Investor Package or such as do not materially and adversely affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company or any of its subsidiaries. Any real property and facilities held under lease by the Company or any of its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries.

 

 

6

 
 

(o)        Foreign Corrupt Practices Act . To the Company’s knowledge, neither the Company, nor any director, officer, agent, employee or other person acting on behalf of the Company or any subsidiary has, in the course of acting for, or on behalf of, the Company, directly or indirectly used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; directly or indirectly made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any similar treaties of the United States; or directly or indirectly made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government or party official or employee.

 

(p)        Tax Status . The Company and each of its subsidiaries has made or filed all United States federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject and all such returns, reports and declarations are true, correct and accurate in all material respects. The Company has paid all taxes and other governmental assessments and charges, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith, for which adequate reserves have been established, in accordance with generally accepted accounting principles.

 

(q)        Compliance with Laws . The business of the Company and its subsidiaries has been and is presently being conducted so as to comply with all applicable material federal, state and local governmental laws, rules, regulations and ordinances.

 

(r)        Employee Benefit Plans; ERISA . Schedule 4 of the Investor Package sets forth a true, correct and complete list of all employee benefit plans, programs, policies and arrangements, whether written or unwritten (the “ Company Plans ”), that the Company, any subsidiary or any other corporation or business which is now or at the relevant time was a member of a controlled group of companies or trades or businesses including the Company or any subsidiary, within the meaning of section 414 of the Internal Revenue Code of 1986, as amended (the “ Code ”), maintain or have maintained on behalf of current or former members, partners, principals, directors, officers, managers, employees, consultants or other personnel. (i) There has been no prohibited transaction within the meaning of Section 406 of the Employee Retirement Income Security Act of 1974, as amended (“ ERISA ”), or Section 4975 of the Code, with respect to any of the Company Plans; (ii) none of the Company Plans is or was subject to Section 412 of the Code or Section 302 or Title IV of ERISA; and (iii) each of the Company Plans has been operated and administered in all material respects in accordance with all applicable laws, including ERISA. There are no actions, suits or claims pending or threatened (other than routine claims for benefits), whether by participants, the Internal Revenue Service, the Department of Labor or otherwise, with respect to any Company Plan and no facts exist under which any such actions, suits or claims are likely to be brought or under which the Company or any subsidiary could incur any liability with respect to a Company Plan other than in the ordinary course. None of the Company Plans is or was a multiemployer plan within the meaning of Section 3(37) of ERISA. Neither the Company nor any subsidiary has announced, proposed or agreed to any change in benefits under any Company Plan or the establishment of any new Company Plan. There have been no changes in the operation or interpretation of any Company Plan since the most recent annual report, which would have any material effect on the cost of operating, maintaining or providing benefits under such Company Plan. Neither the Company nor any subsidiary has incurred any liability for the misclassification of employees as leased employees or independent contractors. Except as provided for in this Subscription Agreement and in the other Sale Documents, the consummation of the transactions contemplated by this Subscription Agreement, either alone or in combination with another event, will not (A) result in any individual becoming entitled to any increase in the amount of compensation or benefits or any additional payment from the Company or any subsidiary (including, without limitation, severance, golden parachute or bonus payments or otherwise), or (B) accelerate the vesting or timing of payment of any benefits or compensation payable in respect of any individual.

(s)        Restrictions on Business Activities . There is no judgment, order, decree, writ or injunction binding upon the Company or any subsidiary or, to the knowledge of the Company or any subsidiary, threatened that has or could prohibit or impair the conduct of their respective businesses as currently conducted or any business practice of the Company or any subsidiary, including the acquisition of property, the provision of services, the hiring of employees or the solicitation of clients, in each case either individually or in the aggregate.

 

4.                  Legends . The Subscriber understands and agrees that the Company will cause any necessary legends in addition to representations to be placed upon the Securities, together with any other legend that may be required by federal or state securities laws or deemed necessary or desirable by the Company, in the form substantially as follows:

 

 

7

 
 

THE SECURITIES WHICH ARE REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNTIL A REGISTRATION STATEMENT WITH RESPECT THERETO IS DECLARED EFFECTIVE UNDER SUCH ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE COMPANY THAT AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT IS AVAILABLE.

 

5.                  Volume Warrants . The Subscriber and the Company hereby agree to the terms and conditions for volume common stock purchase warrants (the “ Volume Warrants ”), as more fully set forth on Exhibit C hereto.

 

6.                  General Provisions.

 

(a)                Confidentiality . The Subscriber covenants and agrees that it will keep confidential and will not disclose or divulge any confidential or proprietary information that such Subscriber may obtain from the Company pursuant to financial statements, reports, and other materials submitted by the Company to such Subscriber in connection with this Transaction or as a result of discussions with or inquiry made to the Company, unless such information is known, or until such information becomes known, to the public through no action by the Subscriber; provided , however , that a Subscriber may disclose such information to its attorneys, accountants, consultants, and other professionals to the extent necessary in connection with his or her investment in the Company so long as any such professional to whom such information is disclosed is made aware of the Subscriber’s obligations hereunder and such professional agrees to be likewise bound as though such professional were a party hereto.

 

(b)               Successors . The covenants, representations and warranties contained in this Subscription Agreement shall be binding on the Subscriber’s and the Company’s heirs and legal representatives and shall inure to the benefit of the respective successors and assigns of the Company. The rights and obligations of this Subscription Agreement may not be assigned by any party without the prior written consent of the other party.

 

(c)                Counterparts . This Subscription Agreement may be executed in counterparts, each of which shall be deemed an original agreement, but all of which together shall constitute one and the same instrument.

 

(d)               Execution by Facsimile or Email . Execution and delivery of this Subscription Agreement by facsimile transmission or email (including the delivery of documents in Adobe PDF format or other machine-readable electronic format) shall constitute execution and delivery of this Subscription Agreement for all purposes, with the same force and effect as execution and delivery of an original manually signed copy hereof.

 

(e)                Governing Law and Jurisdiction . This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Florida applicable to contracts to be wholly performed within such state and without regard to conflicts of law provisions that would result in the application of any laws other than the laws of the State of Florida. Any legal action or proceeding arising out of or relating to this Subscription Agreement and/or the other Sale Documents may be instituted in the courts of the State of Georgia sitting in Fulton County or in the United States District Court for the Northern District of Georgia, and the parties hereto irrevocably submit to the jurisdiction of each such court in any action or proceeding. Subscriber hereby irrevocably waives and agrees not to assert, by way of motion, as a defense, or otherwise, in every suit, action or other proceeding arising out of or based on this Subscription Agreement and/or the other Sale Documents and brought in any such court, any claim that Subscriber is not subject personally to the jurisdiction of the above named courts, that Subscriber’s property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper.

 

(f)                Indemnification Generally .

 

 

8

 
 

(i)                 The Company, on the one hand, and the Subscriber, on the other hand (each an “ Indemnifying Party ”), shall indemnify the other from and against any and all losses, damages, liabilities, claims, charges, actions, proceedings, demands, judgments, settlement costs and expenses of any nature whatsoever (including, without limitation, reasonable attorneys’ fees and expenses) resulting from any breach of a representation and warranty, covenant or agreement by the Indemnifying Party and all claims, charges, actions or proceedings incident to or arising out of the foregoing.

 

(ii)               Indemnification Procedures . Each person entitled to indemnification under this Section 5 (an “ Indemnified Party ”) shall give notice as promptly as reasonably practicable to each party required to provide indemnification under this Section 5 of any action commenced against or by it in respect of which indemnity may be sought hereunder, but failure to so notify an Indemnifying Party shall not release such Indemnifying Party from any liability that it may have, otherwise than on account of this indemnity agreement so long as such failure shall not have materially prejudiced the position of the Indemnifying Party. Upon such notification, the Indemnifying Party shall assume the defense of such action if it is a claim brought by a third party, and, if and after such assumption, the Indemnifying Party shall not be entitled to reimbursement of any expenses incurred by it in connection with such action except as described below. In any such action, any Indemnified Party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless (A) the Indemnifying Party and the Indemnified Party shall have mutually agreed to the contrary, or (B) the named parties in any such action (including any impleaded parties) include both the Indemnifying Party and the Indemnified Party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing or conflicting interests between them. The Indemnifying Party shall not be liable for any settlement of any proceeding effected without its written consent (which shall not be unreasonably withheld or delayed by such Indemnifying Party), but if settled with such consent or if there be final judgment for the plaintiff, the Indemnifying Party shall indemnify the Indemnified Party from and against any loss, damage or liability by reason of such settlement or judgment.

 

(g)               Notices . All notices, requests, demands, claims and other communications hereunder shall be in writing and shall be delivered by certified or registered mail (first class postage pre-paid), guaranteed overnight delivery, or facsimile transmission if such transmission is confirmed by delivery by certified or registered mail (first class postage pre-paid) or guaranteed overnight delivery, to the following addresses and facsimile numbers (or to such other addresses or facsimile numbers which such party shall subsequently designate in writing to the other party):

 

(i)       if to the Company:

[REDACTED]

 

with a copy to:

[REDACTED]

 

(ii)       If to Subscriber, to the address set forth next to its name on the signature page hereto.

 

(h)               Entire Agreement . This Subscription Agreement (including the exhibits attached hereto) and other Sale Documents delivered at the Closing pursuant hereto, contain the entire understanding of the parties in respect of its subject matter and supersedes all prior agreements and understandings between or among the parties with respect to such subject matter. The exhibits constitute a part hereof as though set forth in full above.

 

 

9

 
 

(i)                 Amendment; Waiver . This Subscription Agreement may not be modified, amended, supplemented, canceled or discharged, except by written instrument executed by both parties. No failure to exercise and no delay in exercising, any right, power or privilege under this Subscription Agreement shall operate as a waiver, nor shall any single or partial exercise of any right, power or privilege hereunder preclude the exercise of any other right, power or privilege. No waiver of any breach of any provision shall be deemed to be a waiver of any proceeding or succeeding breach of the same or any other provision, nor shall any waiver be implied from any course of dealing between the parties. No extension of time for performance of any obligations or other acts hereunder or under any other agreement shall be deemed to be an extension of the time for performance of any other obligations or any other acts. The rights and remedies of the parties under this Subscription Agreement are in addition to all other rights and remedies, at law or equity, that they may have against each other.

 

 

[Signature Page Follows]

 

10

 
 

  

INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL 

 

THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL

 

OMNIBUS SIGNATURE PAGE TO THE SUBSCRIPTION AGREEMENT

TO PURCHASE SAFETY QUICK LIGHTING & FAN CORP.’S COMMON STOCK

 

DOLLAR AMOUNT INVESTED: US $ ____________________________

 

NUMBER OF SHARES SUBSCRIBED FOR: ____________________________

 

AMOUNT INVESTED TO BE SENT VIA: [ ] Check (enclosed) [ ] Wire

 

 

NAME IN WHICH THE SECURITIES SHOULD BE ISSUED:

   

_________________________________________________________________________________________________

SUBSCRIBER ADDRESS INFORMATION:

For individual subscribers this address should be the Subscriber’s primary legal residence. For entities other than individual subscribers, please provide address information for the entities primary place of business.

 

     
Legal Address   Copy To
     
City, State and Zip Code   Legal Address
     
Tax ID (EIN, SSN, OR ITIN)   City, State and Zip Code
     
Telephone Number / Facsimile Number   Telephone Number / Facsimile Number
     
Email Address   Email Address

 

ALTERNATE ADDRESS INFORMATION:

Please enter an alternate address if you wish to receive correspondence at an address other than the address listed above.

 

     
Alternative Address for Correspondence   Alternative Address for Correspondence
     
City, State and Zip Code   City, State and Zip Code
     
Other (telephone, fax, email)   Other (telephone, fax, email)

 

AGREED AND SUBSCRIBED   AGREED AND SUBSCRIBED  
       
Date:   Date:  
Subscriber:      
By:   SQL TECHNOLOGIES CORP  
Name:      
Title:   By:  
      John P. Campi
      Chief Executive Officer

 

11

 
 

CERTIFICATE OF SIGNATORY

 

(To be completed if the Securities are

being subscribed for by an entity)

 

 

I, , am the_______________________________ of (the “ Entity ”).

 

I certify that I am empowered and duly authorized by the Entity to execute and carry out the terms of the Securities Subscription Agreement and to purchase and hold the Securities, and certify further that the Securities Subscription Agreement has been duly and validly executed on behalf of the Entity and constitutes a legal and binding obligation of the Entity.

 

IN WITNESS WHEREOF, I have set my hand this ____ day of __________, 2016.

 

 

______________________________________

(Signature)

 

 

12

 
 

 

Exhibit A

 

STOCK OPTION AGREEMENT

 

TO PURCHASE UP TO 30,000 SHARES OF COMMON STOCK

OF SQL TECHNOLOGIES CORP.

 

THIS STOCK OPTION AGREEMENT (this “ Agreement ”) is made as of August ___, 2016 (the “ Effective Date ”) by and between SQL TECHNOLOGIES CORP , a Florida corporation (the “ Company ”), and _______ (the “ Optionee ”).

 

WHEREAS, the Optionee subscribed for (i) up to 30,000 shares of the Company’s common stock, no par value per share (“ Common Stock ”), (ii) a 90-day option to purchase up to the same number of shares of Common Stock purchased by the Subscriber in the closing of the Transaction, (iii) three-year warrants to purchase shares of Common Stock, and (iv) the right to obtain certain volume warrants (collectively, the “ Securities ”), pursuant to the terms set forth in a Securities Subscription Agreement dated as of the date hereof (the “ Subscription Agreement ”, together with the Company’s Investor Package dated August 2016 and distributed to Optionee, the “ Sale Documents ”). Any capitalized term not defined herein shall have the meaning of such term as has been set forth in the Sale Documents.

 

1.        Grant of Option . Subject to the terms and conditions set forth in this Agreement, the Company hereby grants to the Optionee the option, whereby the Optionee shall have the right purchase from the Company, during the period set forth in Section 2, up to thirty thousand (30,000) shares of Common Stock (“ Option Shares ”) at an exercise price of US $2.60 (two dollars and sixty cents US) (the “ Exercise Price ”, and such right to purchase the Option Shares at the Exercise Price, the “ Option ”).

 

2.        Term . This Agreement and the Option shall be forfeited and terminate automatically, without further action or notice, on the ninety (90) day anniversary of the Effective Date (the “ Expiration Date ”). The right to purchase the Option Shares under the Option shall vest to the Optionee immediately. Notwithstanding any other provision of this Agreement, the Option shall not vest or be exercisable if the exercise thereof would result in a violation of any applicable federal or state securities law.

 

3.        Exercise of Option .

 

(a)       Exercise of the purchase rights represented by the Option may be made at any time or times on or before the Expiration Date by delivery to the Company of a duly executed Notice of Exercise Form annexed hereto (or such other office or agency of the Company as it may designate by notice in writing to the Optionee at the address of such Optionee appearing on the books of the Company) and surrender of this Agreement, together with payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank in immediately available funds. The Option may not be exercised for less than ten thousand (10,000) Option Shares, and may only be exercised in increments of five thousand (5,000) Option Shares, unless otherwise agreed to by the Company.

 

(b)       The Option shall be deemed to have been exercised on the later of the date the Notice of Exercise is delivered to the Company and the date the Exercise Price is received by the Company. The Option Shares shall be deemed to have been issued, and Optionee or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Option has been exercised by payment to the Company of the Exercise Price and all taxes required to be paid by the Optionee, if any, have been paid.

 

(c)       The Company and the Optionee agree that, to the extent applicable, unless and until registered under the Securities Act of 1933, as amended, which registration remains effective, all shares of Common Stock acquired by the Optionee upon exercise of the Option, may be stamped or otherwise imprinted with legends in substantially the following form:

 

 

13

 
 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF ANY EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND SUCH LAWS OR AN EXEMPTION FROM REGISTRATION THEREUNDER.

 

4.        Adjustments and Restrictions .

 

(a)       Upon the occurrence of an event affecting the capitalization of the Company, such as a stock split, reclassification, merger or otherwise, the Company shall preserve the benefits or potential benefits intended to be made available hereunder, either by equitably increase or decrease the number of Option Shares, changing the kind of shares available under the Option, or increasing or decreasing the Exercise Price of the Option.

 

(b)        The Optionee shall have no rights as a shareholder with respect to any shares of Common Stock covered by the Option until the date of the issuance of a certificate or certificates for the shares for which the Option has been exercised. No adjustment shall be made for dividends or distributions or other rights for which the record date is prior to the date such certificate or certificates are issued.

 

(c)       The Company shall not be required (i) to transfer on its books any Options Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Option Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such shares shall have been so transferred.

 

(d)       The Option may not be transferred, assigned, sold, hypothecated or pledged by the Optionee without the prior written consent of the Company. Subject to applicable securities laws, the Option and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Optionee.

 

(e)       Optionee acknowledges that the Option Shares acquired upon the exercise of the Option, if not registered for resale, will have restrictions upon resale imposed by state and federal securities laws.

 

(f)       The Optionee represents and warrants that the Optionee is acquiring the Option and shares of Common Stock issuable upon exercise thereof for the Optionee's own account as an investment and not with a view toward the sale or distribution thereof.

 

5.        Miscellaneous .

 

(a)        All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts to be wholly performed within such state and without regard to conflicts of law provisions that would result in the application of any laws other than the laws of the State of New York. Any legal action or proceeding arising out of or relating to this Agreement may be instituted in the courts of the State of New York sitting in New York County or in the United States of America for the Southern District of New York, and the parties hereto irrevocably submit to the jurisdiction of each such court in any action or proceeding. Optionee hereby irrevocably waives and agrees not to assert, by way of motion, as a defense, or otherwise, in every suit, action or other proceeding arising out of or based on this Agreement and brought in any such court, any claim that Optionee is not subject personally to the jurisdiction of the above named courts, that Optionee’s property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper.

 

 

14

 
 

(b)        This Agreement may not be modified or amended, or the provisions hereof waived, without the prior written agreement of the Company and Optionee. No course of dealing or any delay or failure to exercise any right hereunder on the part of Optionee shall operate as a waiver of such right or otherwise prejudice Optionee’s rights, powers or remedies, notwithstanding all rights hereunder terminate on the Expiration Date. The headings used in this Agreement are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Agreement. Wherever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Agreement.

 

(c)       Any notice, request or other document required or permitted to be given or delivered to the Optionee by the Company shall be delivered in accordance with the notice provisions of the Subscription Agreement.

 

(d)       The Participant is responsible for any federal, state, local or other taxes with respect to the Option Shares. The Company does not guarantee any particular tax treatment or results in connection with the grant or vesting of the Option Shares or the delivery of the Option Shares.

 

(e)       This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together constitute one agreement.

 

[Signature Page Follows]

 

15

 
 

 

IN WITNESS WHEREOF, the parties hereto have caused this Stock Option Agreement to be executed as of the Effective Date.

 

Optionee: Company:
  SQL TECHNOLOGIES Corp.
_____________________________________  
   
By: _________________________________ By: ___________________________________
Name: _______________________________ Name: John P. Campi
Title: ________________________________ Title: Chief Executive Officer

 

 

16

 
 

 

NOTICE OF EXERCISE

 

To: SQL Technologies Corp.

 

(1) The undersigned hereby elects to purchase                      Option Shares of the Company pursuant to the terms of the attached Option, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Please issue a certificate or certificates representing said Option Shares in the name of the undersigned or in such other name as is specified below:

 

(3) The Option Shares shall be delivered to the following:

 

(4) The undersigned is an “accredited investor” as defined in Regulation D under the Securities Act of 1933, as amended.

 

 

(OPTIONEE)

 

By: _____________________________________

 

Name: _____________________________________

 

Title: _____________________________________

 

Dated: _____________________________________

     
 

17

 
 

 

ASSIGNMENT FORM

 

(To assign the foregoing Stock Option Agreement, execute this form and supply required information.

Do not use this form to exercise the Option.)

 

FOR VALUE RECEIVED, the foregoing Stock Option Agreement and all rights evidenced thereby, including the Option, are hereby assigned to:

 

                                                                                   

 

whose address is:

 

                                                                                   

 

                                                                                   

 

                                                                                   

 

 

 

     
    Dated:                      ,             
   
Optionee’s Signature   _______________________________________
   
Optionee’s Address:   _______________________________________
   
    _______________________________________
   
    _______________________________________

 

 

     
Signature Guaranteed:  

 

 

     

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Stock Option Agreement, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Stock Option Agreement.

 

 

18

 
 

Exhibit B

 

NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY ONLY BE ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT, IF ANY, MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT AND QUALIFICATION UNDER APPLICABLE STATE LAW WITHOUT AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED UNDER THE ACT OR RECEIPT OF A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION.

  

COMMON STOCK PURCHASE WARRANT

 

To Purchase _____ Shares of Common Stock of

 

SQL TECHNOLOGIES CORP.

 

June ___, 2016 (the “ Issuance Date ”)

 

THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) CERTIFIES that, for value received, ______ (the “ Holder ”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of this Warrant and on or prior to the third anniversary of the date of this Warrant (the “ Termination Date ”) but not thereafter, to subscribe for and purchase from SQL Technologies Corp., a Florida corporation (the “ Company ”), up to _____ shares (the “ Warrant Shares ”) of the Common Stock, no par value per share, of the Company (the “ Common Stock ”). The purchase price of one share of Common Stock (the “ Exercise Price ”) under this Warrant shall be (i) US $3.00 (three dollars US) if exercised prior to the one year anniversary of the Issuance Date, (ii) $3.25 (three dollars and twenty-five cents US) if exercised on or after the one year anniversary and before the two year anniversary of the Issuance Date, or (iii) $3.50 (three dollars and fifty cents US) if exercised on or after the two year anniversary and through the Termination Date.

 

The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Subscription Agreement (the “ Subscription Agreement ”), dated as of _______, 2016, among the Company and the Purchaser parties signatory thereto.

 

1.         Title to Warrant . Prior to the Termination Date and subject to compliance with applicable laws, including transfer restrictions imposed by applicable securities laws, and Section 7 of this Warrant, this Warrant and all rights hereunder are transferable, in whole or in part, at the office or agency of the Company by the Holder in person or by duly authorized attorney, upon surrender of this Warrant together with the Assignment Form annexed hereto properly endorsed. The transferee shall sign an investment letter in form and substance reasonably satisfactory to the Company.

 

2         Authorization of Shares . The Company covenants that all Warrant Shares, which may be issued upon the exercise of the purchase rights represented by this Warrant in accordance with the terms of this Warrant, including the payment of the exercise price for such Warrant Shares, will, upon exercise of the purchase rights represented by this Warrant, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

 

19

 
 

3.         Exercise of Warrant .

 

(a)        Exercise of the purchase rights represented by this Warrant may be made at any time or times on or before the Termination Date by delivery to the Company of a duly executed Notice of Exercise Form annexed hereto (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of such Holder appearing on the books of the Company) and surrender of this Warrant, together with payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank in immediately available funds. Certificates for shares purchased hereunder shall be delivered to the Holder within 5 Trading Days from the delivery to the Company of the Notice of Exercise Form, surrender of this Warrant and payment of the aggregate Exercise Price as set forth above (“ Warrant Share Delivery Date ”). This Warrant shall be deemed to have been exercised on the later of the date the Notice of Exercise is delivered to the Company and the date the Exercise Price is received by the Company. The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised by payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, pursuant to Section 5 prior to the issuance of such shares, have been paid. If the Company fails to deliver to the Holder a certificate or certificates representing the Warrant Shares pursuant to this Section 3(a) by the end of business (New York, New York time) on the fifth Trading Day following the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

(b)        If this Warrant shall have been exercised in part, the Company shall, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to Holder a new Warrant evidencing the rights of Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

(c)        If at any time after one year from the date of issuance of this Warrant, there is no effective Registration Statement registering the resale of the Warrant Shares by the Holder at such time, this Warrant may also be exercised at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = the VWAP on the Trading Day immediately preceding the date of such election;

 

(B) = the Exercise Price of this Warrant, as adjusted; and

 

(X) = the number of Warrant Shares issuable upon exercise of this Warrant in accordance with the terms of this Warrant by means of a cash exercise rather than a cashless exercise.

 

VWAP ” shall mean, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg Financial L.P. (based on a trading day from 9:30 a.m. Eastern Time to 4:02 p.m. Eastern Time); (b) if the Common Stock is not then listed or quoted on a Trading Market and if prices for the Common Stock are then reported in the “Pink Sheets” published by the National Quotation Bureau Incorporated (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported; or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers and reasonably acceptable to the Company.

 

4.         No Fractional Shares or Scrip . No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which Holder would otherwise be entitled to purchase upon such exercise, the Company shall pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price.

 

 

20

 
 

5.         Charges, Taxes and Expenses . Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder; and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.

 

6.         Closing of Books . The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

7.         Transfer, Division and Combination .

 

(a)        Subject to compliance with any applicable securities laws and the conditions set forth in Sections 1 and 7(e) hereof, and to the provisions of Section 4 of the Subscription Agreement, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. A Warrant, if properly assigned, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

(b)        This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 7(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.

 

(c)        The Company shall prepare, issue and deliver at its own expense (other than transfer taxes) the new Warrant or Warrants under this Section 7.

 

(d)        The Company agrees to maintain, at its aforesaid office, books for the registration and the registration of transfer of the Warrants.

 

(e) The Company may require, as a condition of allowing such transfer (i) that the Holder or transferee of this Warrant, as the case may be, furnish to the Company a written opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect that such transfer may be made without registration under the Securities Act and under applicable state securities or blue sky laws, (ii) that the holder or transferee execute and deliver to the Company an investment letter in form and substance acceptable to the Company and (iii) that the transferee be an “accredited investor” as defined in Rule 501(a) promulgated under the Securities Act or a qualified institutional buyer as defined in Rule 144A(a) under the Securities Act.

 

8.         No Rights as Shareholder until Exercise . This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder of the Company prior to the exercise hereof. Upon the surrender of this Warrant and the payment of the aggregate Exercise Price (or by means of a cashless exercise), the Warrant Shares so purchased shall be and be deemed to be issued to such Holder as the record owner of such shares as of the close of business on the later of the date of such surrender or payment.

 

9.         Loss, Theft, Destruction or Mutilation of Warrant . The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

 

21

 
 

10.         Saturdays, Sundays, Holidays, etc . If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday, Sunday or a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday, Sunday or legal holiday.

 

11.         Adjustments of Exercise Price and Number of Warrant Shares . The number and kind of securities purchasable upon the exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time in the event that the Company: (i) pays a dividend in shares of Common Stock or make a distribution in shares of Common Stock to holders of its outstanding Common Stock; (ii) subdivides its outstanding shares of Common Stock into a greater number of shares; (iii) combines its outstanding shares of Common Stock into a smaller number of shares of Common Stock; or (iv) issues any shares of its capital stock in a reclassification of the Common Stock, then the number of Warrant Shares purchasable upon exercise of this Warrant immediately prior thereto shall be adjusted so that the Holder shall be entitled to receive the kind and number of Warrant Shares or other securities of the Company which it would have owned or have been entitled to receive had such Warrant been exercised in advance thereof. Upon each such adjustment of the kind and number of Warrant Shares or other securities of the Company which are purchasable hereunder, the Holder shall thereafter be entitled to purchase the number of Warrant Shares or other securities resulting from such adjustment at an Exercise Price per Warrant Share or other security obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of Warrant Shares purchasable pursuant hereto immediately prior to such adjustment and dividing by the number of Warrant Shares or other securities of the Company that are purchasable pursuant hereto immediately after such adjustment. An adjustment made pursuant to this paragraph shall become effective immediately after the effective date of such event retroactive to the record date, if any, for such event.

 

12.         Subsequent Equity Sales . In the event that on or subsequent to the Issuance Date, the Company issues or sells any Common Stock, any securities which are convertible into or exchangeable for its Common Stock or any convertible securities, or any warrants or other rights to subscribe for or to purchase or any options for the purchase of its Common Stock or any such convertible securities (the “ Common Stock Equivalents ”) (other than (i) securities which are issued pursuant to the Subscription Agreement or this Warrant, (ii) shares of Common Stock or options to purchase such shares issued to employees, consultants, officers or directors in accordance with stock plans approved by the Board of Directors, and shares of Common Stock issuable under options or warrants that are outstanding as of the date hereof or issued pursuant to any stock incentive plan authorized by the Board of Directors, and (iii) shares of Common Stock issued pursuant to a stock dividend, split or other similar transaction) at an effective price per share which is less than the Exercise Price, then the Exercise Price in effect immediately prior to such issue or sale shall be reduced to the lowest per share price of Common Stock in such issuance or sale or deemed issuance or sale.

 

13.         Reorganization, Reclassification, Merger, Consolidation or Disposition of Assets . In case the Company shall reorganize its capital, reclassify its capital stock, consolidate or merge with or into another corporation (where the Company is not the surviving corporation or where there is a change in or distribution with respect to the Common Stock of the Company), or sell, transfer or otherwise dispose of its property, assets or business to another corporation and, pursuant to the terms of such reorganization, reclassification, merger, consolidation or disposition of assets, shares of common stock of the successor or acquiring corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu of common stock of the successor or acquiring corporation (“ Other Property ”), are to be received by or distributed to the holders of Common Stock of the Company, then, from and after the consummation of such transaction or event, the Holder shall have the right thereafter to receive, instead of the Warrant Shares, at the option of the Holder, (a) upon exercise of this Warrant, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a Holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event or (b) cash equal to the value of this Warrant as determined in accordance with the Black-Scholes option pricing formula. For purposes of this Section 13, “common stock of the successor or acquiring corporation” shall include stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption and shall also include any evidences of indebtedness, shares of stock or other securities which are convertible into or exchangeable for any such stock, either immediately or upon the arrival of a specified date or the happening of a specified event and any warrants or other rights to subscribe for or purchase any such stock. The foregoing provisions of this Section 13 shall similarly apply to successive reorganizations, reclassifications, mergers, consolidations or disposition of assets.

 

 

22

 
 

14.         Notice of Adjustment . Whenever the number of Warrant Shares or number or kind of securities or other property purchasable upon the exercise of this Warrant or the Exercise Price is adjusted, as herein provided, the Company shall give notice thereof to the Holder, which notice shall state the number of Warrant Shares (and other securities or property) purchasable upon the exercise of this Warrant and the Exercise Price of such Warrant Shares (and other securities or property) after such adjustment, setting forth a brief statement of the facts requiring such adjustment and setting forth the computation by which such adjustment was made.

 

15.         Notice of Corporate Action . If at any time:

 

(a)        the Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend or other distribution, or

 

(b)        there shall be any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any consolidation or merger of the Company with, or any sale, transfer or other disposition of all or substantially all the property, assets or business of the Company to, another corporation or,

 

(c)        there shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company;

 

then, in any one or more of such cases, the Company shall give to Holder (i) prior written notice of the date on which a record date shall be selected for such dividend or distribution or for determining rights to vote in respect of any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, liquidation or winding up, and (ii) in the case of any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up, prior written notice of the date when the same shall take place. Such notice in accordance with the foregoing clause also shall specify (i) the date on which the holders of Common Stock shall be entitled to any such dividend or distribution, and the amount and character thereof, and (ii) the date on which any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up is to take place and the time, if any such time is to be fixed, as of which the holders of Common Stock shall be entitled to exchange their Warrant Shares for securities or other property deliverable upon such disposition, dissolution, liquidation or winding up. Each such written notice shall be sufficiently given if addressed to Holder at the last address of Holder appearing on the books of the Company and delivered in accordance with Section 16(d).

 

16.         Authorized Shares . The Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

 

23

 
 

17.         Miscellaneous .

 

(a)         Jurisdiction . All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts to be wholly performed within such state and without regard to conflicts of law provisions that would result in the application of any laws other than the laws of the State of New York. Any legal action or proceeding arising out of or relating to this Warrant may be instituted in the courts of the State of New York sitting in New York County or in the United States of America for the Southern District of New York, and the parties hereto irrevocably submit to the jurisdiction of each such court in any action or proceeding. Holder hereby irrevocably waives and agrees not to assert, by way of motion, as a defense, or otherwise, in every suit, action or other proceeding arising out of or based on this Warrant and brought in any such court, any claim that Holder is not subject personally to the jurisdiction of the above named courts, that Holder’s property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper.

 

(b)         Restrictions . The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered for resale, will have restrictions upon resale imposed by state and federal securities laws.

 

(c)         Nonwaiver and Expenses . No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder’s rights, powers or remedies, notwithstanding all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

(d)         Notices . Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Subscription Agreement.

 

(e)         Limitation of Liability . No provision hereof, in the absence of any affirmative action by Holder to exercise this Warrant or purchase Warrant Shares, and no enumeration herein of the rights or privileges of Holder, shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

(f)         Successors and Assigns . Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by any such Holder or holder of Warrant Shares.

 

(g)         Amendment . This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(h)         Severability . Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(i)         Headings . The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

[Signature Page Follows]

 

24

 
 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed as of the Issuance Date by its officer thereunto duly authorized.

       
SQL TECHNOLOGIES CORP.
 

 

 

 
By:  

 

 

 
       John P. Campi   
    President & CEO    

 

 

25

 
 

 

NOTICE OF EXERCISE

 

To: SQL Technologies Corp.

 

(1) The undersigned hereby elects to purchase                      Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

[ ] in lawful money of the United States; or

 

[ ] the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 3(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 3(c).

 

(3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

 

 

(4) The Warrant Shares shall be delivered to the following:

 

 

 

 

(5) The undersigned is an “accredited investor” as defined in Regulation D under the Securities Act of 1933, as amended.

 

(PURCHASER)

 

By: _____________________________________

 

Name: _____________________________________

 

Title: _____________________________________

 

Dated: _____________________________________

     
 

26

 
 

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute this form and supply required information.

Do not use this form to exercise the warrant.)

 

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to:

 

                                                                                   

 

whose address is:

 

                                                                                   

 

                                                                                   

 

                                                                                    .

 

     
    Dated:                      ,             
   
Holder’s Signature   _______________________________________
   
Holder’s Address:   _______________________________________
   
    _______________________________________
   
    _______________________________________

 

     
Signature Guaranteed:  

 

 

 

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

Exhibit C

 

Volume Warrants

 

_______ (“ Recipient ”) shall be entitled to receive Common Stock Purchase Warrants to purchase up to an additional 120,000 shares of the common stock, no par value per share (“ Common Stock ”), of the Company (each a “ Volume Warrant ” and collectively, the “ Volume Warrants ”). Each Volume Warrant shall become issuable as provided below, and any issued Volume Warrant will be exercisable commencing on the date it is issued and ending on the date that is prior to the later of (i) five (5) years from the date of issuance or (ii) thirty (30) days from the date Recipient is notified of the EBITDA (as defined herein) for the year ending December 31, 2020 (the “ Volume Warrant Term ”).

 

Subject to adjustment as described below, the exercise price of one share of Common Stock (the “ Exercise Price ”) will be $3.00 per share.

 

 

27

 
 

A portion of the Volume Warrants to purchase up to ______ shares of Common Stock will, from time to time, become issuable by Recipient upon (i) the Company achieving specific EBITDA Valuation (as defined below) thresholds in any fiscal year (January 1 through December 31) prior to December 31, 2020, (ii) each applicable Financing Transaction (as defined herein) or (iii) each Sales Transaction (as defined herein) prior to December 31, 2020.

 

The form of the Volume Warrants will be substantially in the form attached hereto as Exhibit B (the “ Form of Warrant ”), with such number of shares issuable pursuant to a Volume Warrant and such Exercise Price thereto subject to adjustment under the same terms as set forth in Sections 11 through 14 of the Form of Warrant, and with such rights of the Holder thereof to notice of a corporate action and right to the exchange of securities under the terms set forth in Section 15 of the Form of Warrant, and in the case of Section 11, based on the Company’s capitalization as of the Closing Date (as defined in the Securities Subscription Agreement).

 

1. Company Valuation

Volume Warrants to purchase shares of Common Stock will become issuable in accordance with the following schedule:

 

Upon the Company Achieving EBITDA Valuation of:

Number of Volume Warrants Issuable

to Purchase Common Stock

One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000
$1,000,000 or over 40,000 120,000

 

Volume Warrants will become issuable only once upon the achievement of each threshold during the Volume Warrant Term.

Within one hundred and twenty (120) days of the end of each fiscal (calendar) year, the Company shall cause its accountants to calculate the Company’s EBITDA for the immediately preceding calendar year and deliver its calculation of this EBITDA to the Company and to Recipient. Recipient’s Volume Warrants that become issuable pursuant to this Section 1 will be deemed issuable as of the date Recipient is notified of the EBITDA Valuation.

 

For Example:

 

If the Company’s EBITDA for 2017 is $47,000,000, which equates to an EBITDA Valuation of $611,000,000, then Recipient’s Volume Warrants to purchase up to 55,000 shares of the Company’s Common Stock will become issuable (35,000 + 20,000).

 

Upon the Company Achieving EBITDA Valuation of: Number of Volume Warrants Issuable to Purchase Common Stock
One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000

 

If the Company’s EBITDA for 2018 is equal to its EBITDA for 2017 of $47,000,000 then Recipient’s other Volume Warrants to purchase shares of Common Stock will not become issuable based upon the Company’s EBITDA for 2018 since a new threshold is not accomplished.

 

 

28

 
 

If, however, the Company’s EBITDA for 2017 is $47,000,000 (which equates to $611,000,000 EBITDA Valuation) and the Company’s EBITDA for 2018 is $70,000,000 (which equates to $910,000,000 EBITDA Valuation), Recipient’s Volume Warrants to purchase up to 80,000 shares of Common Stock would immediately become issuable.

 

Upon the Company Achieving EBITDA Valuation of: Number of Volume Warrants Issuable to Purchase Common Stock
One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000

 

2. Financing Event .

At each and every Transaction (as defined herein) in which the Company completes a Financing (as defined herein) of at least $15,000,000 (in one or more closings within a twelve (12) month period), Recipient’s Volume Warrants to purchase shares of Common Stock will become issuable in accordance with the following schedule:

 

 

Pre-Money Valuation

Number of Volume Warrants Issuable

to Purchase Common Stock

One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000
$1,000,000,000 or more 40,000 120,000

 

Recipient’s Volume Warrants to purchase shares of Common Stock will become issuable at each threshold in the above schedule only once.

 

For Example:

If the Company has a $15,000,000 Financing (in one or more closings within a 12 month time period) with a Pre-Money Valuation of $600,000,000, then Recipient’s Volume Warrants to purchase up to 55,000 shares of Common Stock will become issuable (35,000 + 20,000).

 

 

Pre-Money Valuation

 

Number of Volume Warrants Issuable

to Purchase Common Stock

One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000
$1,000,000,000 or more 40,000 120,000

 

If the Company has a second Financing of at least $15,000,000 (in one or more closings within a 12 month time period) with a Pre-Money Valuation of $900,000,000, Recipient’s Volume Warrants to purchase up to 25,000 shares of Common Stock will become issuable bringing the total number of shares of Common Stock Recipient may purchase from the Volume Warrants that become issuable under this Section 2 to 80,000 shares (35,000 + 20,000 + 25,000).

 

 

29

 
 

 

Pre-Money Valuation

 

Number of Volume Warrants Issuable

to Purchase Common Stock

One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000
$1,000,000,000 or more 40,000 120,000

 

If the Company has a third Financing of at least $15,000,000 (in one or more closings within a 12 month time period) with a Pre-Money Valuation of $1,100,000,000, Recipient’s Volume Warrants to purchase up to 40,000 shares of Common Stock will become issuable, bringing the total number of shares of Common Stock Recipient may purchase from the Volume Warrants that become issuable under this Section 2 to 120,000 shares (35,000 + 20,000 + 25,000+ 40,000).

 

 

Pre-Money Valuation

 

Number of Volume Warrants Issuable

to Purchase Common Stock

One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000
$1,000,000,000 or more 40,000 120,000

 

3. Sales Transaction.

 

Upon the consummation of a Sale Transaction prior to December 31, 2020, Recipient’s Volume Warrants to purchase Common Stock will become issuable in accordance with Section 2 (above); provided, however, upon any Sale Transaction with a Transaction Value (as defined herein) of less than $350,000,000, Recipient’s Volume Warrants to purchase up to 20,000 shares of Common Stock will become issuable.

 

For Example:

 

If the Company has a Sale Transaction with a Transaction Value of $600,000,000, then Recipient’s Volume Warrants to purchase up to 55,000 shares of Common Stock will become issuable (35,000 + 20,000).

 

 

Pre-Money Valuation

 

Number of Volume Warrants Issuable

to Purchase Common Stock

One Time Cumulative
$350,000,000 to $499,999,999 35,000 35,000
$500,000,000 to $749,999,999 20,000 55,000
$750,000,000 to $999,999,999 25,000 80,000
$1,000,000,000 or more 40,000 120,000

 

 

30

 
 

4. Definitions.

Contingent Payments means the consideration received or receivable by the Company, its employees, current equity holders and/or any other parties in the form of deferred performance or retention-based payments, “earn-outs”, or other contingent payments based upon the occurrence of future events.

 

EBITDA means earnings before interest, taxes, depreciation and amortization.

 

EBITDA Valuation means EBITDA multiplied by thirteen (13).

 

Financing means a private placement of equity, equity-linked or debt securities (including, without limitation, any convertible securities, preferred stock, common stock, unsecured, non-senior or subordinated debt securities, senior notes, loans, bank debt, and/or any debt with warrants) (any or all of which being “Securities”) to provide financing involving less than 50% of the business, assets or equity interests of the Company and/or any of its subsidiaries or affiliates, or any right or option to acquire any of the foregoing, or any entity formed by or at the direction of the Company, in one or more transactions.

 

 

31

 
 

Pre-Money Valuation means pre-investment value of the enterprise that is implied by the per-share price of the stock being offered and the number of fully-diluted shares outstanding before the investment. Fully-diluted shares shall include any outstanding shares and contingent equity such as stock options, warrants, and convertible notes in the calculation. For purposes of illustration, if the Company’s shares are valued at $100.00 and it has 5 million shares fully-diluted outstanding prior to any new investment, then the Company has a pre-money valuation of $500 million. Any non-cash consideration provided to or received in connection with a Financing Event (including but not limited to intellectual or intangible property, securities, labor or services rendered, debt ((or cancellation thereof)) or tangible property) shall be valued for purposes of calculating the Pre-Money Valuation as equaling the number of securities issued in exchange for such consideration multiplied by (in the case of debt securities) the face value of each such security or (in the case of equity securities) the price per security paid in the then current round of financing.

 

Sale Transaction means a merger, consolidation, joint venture, partnership, spin-off, split-off, business combination, tender or exchange offer, recapitalization, acquisition, sale, distribution, transfer or other disposition of assets or equity interests, or other transaction, involving more than 50% of the business, assets or equity interests of the Company and/or any of its subsidiaries or affiliates, or any right or option to acquire any of the foregoing, in one or more transactions.

 

Total Consideration means the total proceeds and other consideration paid or received, or to be paid or received, directly or indirectly, in connection with or in anticipation of a Sale Transaction (which consideration shall be deemed to include amounts in escrow), including, without limitation, cash, notes, securities, and other property received or to be received by the Company or any of its affiliates, creditors or security holders (including, without limitation, the holders of convertible securities, options, warrants, stock appreciation rights or similar rights, whether or not vested); deferred non-contingent payments (such as installment payments); amounts payable under above-market consulting agreements, above-market employment contracts, non-compete or severance agreements, employee benefit plans, reimbursement for taxes or similar arrangements; Contingent Payments (as defined below); and, in the case of a partnership, joint venture or similar structure, the gross value of all cash, securities, assets and other consideration contributed, invested, committed, or otherwise made available by the Company or any other parties to such partnership, joint venture or similar structure.

 

For the purpose of calculating the consideration received or receivable in connection with or in anticipation of a Sale Transaction, any securities (other than a promissory note) will be valued at the time of the closing of the Sale Transaction (without regard to any restrictions on transferability) as follows: (i) if such securities are traded on a stock exchange, the securities will be valued at the average last sale or closing price for the ten trading days immediately prior to the closing of the Sale Transaction; (ii) if such securities are traded primarily in over-the-counter transactions, the securities will be valued at weighted average of the mean of the closing bid and asked quotations over a ten trading day period immediately prior to the closing of the Sale Transaction with the weighting based on the number of shares actually traded each day over such ten trading day period; and (iii) if such securities have not been traded in the public market prior to the closing of the Sale Transaction, the securities will be valued at the fair market value thereof as of the day prior to the closing of the Sale Transaction, as such fair market value shall be mutually agreed by Recipient and the Company acting in good faith. The value of any purchase money or other promissory notes, installment sales contracts or other deferred non-contingent consideration shall be deemed to be the face amount thereof, and shall be included as part of the Total Consideration for the purpose of determining the number of Volume Warrants issued to Recipient. In the event the Transaction Value includes any Contingent Payments, the Company and Recipient will negotiate in good faith to agree on the value of such Contingent Payments for the purpose of calculating that the Transaction Value and the number of Volume Warrants issued to Recipient. If the parties cannot reach such an agreement, an additional number of Volume Warrants will be issued to Recipient, if applicable based on the Transaction Value, in the same proportions and at the same times as the Contingent Payments are paid or received. Any other non-cash consideration shall be valued at the fair market value thereof as of the day prior to the closing of the Sale Transaction, as such fair market value shall be mutually agreed by Recipient and the Company acting in good faith.

 

 

32

 
 

Transaction Value means the total value of the Sale Transaction calculated as if 100% of the equity interests of the Company on a fully diluted basis had been sold by dividing the Total Consideration by the percentage of ownership which is sold. The Transaction Value shall include the aggregate principal amount of any debt, pension liabilities, guarantees and any other liabilities or obligations of the Company or any of its affiliates or security holders (i) retired, refinanced, restructured, redeemed, decreased, repaid or extinguished in connection with or anticipation of a Sale Transaction or (ii) assumed in an acquisition of assets or which remain outstanding at the time of closing in all other cases. If any cash or other assets of the Company and/or any of its subsidiaries or affiliates are sold or otherwise transferred to another party after the date hereof (including, without limitation, any dividends, distributions or other amounts paid to option or other security holders, amounts paid to repurchase any securities, or transaction-related bonus payments made to employees), or are retained after the consummation of the Sale Transaction, the Transaction Value will be increased to reflect the fair market value of any such assets. Any part of the Total Consideration held pursuant to an escrow account established before or in connection with the consummation of a Sale Transaction shall be deemed paid or received and not contingent. For purposes of this provision, the Transaction Value shall exclude cash or cash equivalents remaining on the Company’s financial statements at closing of a Transaction.

 

33

 

 

 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, I, John P. Campi, certify that:

 

1. I have reviewed this report on Form 10-Q of SQL Technologies Corp., for the period ended September 30, 2016;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 14, 2016

 

/s/ John P. Campi

John P. Campi

Chief Executive Officer

Principle Executive Officer

 

 

EXHIBIT 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, I, John P. Campi certify that:

 

1. I have reviewed this report on Form 10-Q of SQL Technologies Corp., for the period ended September 30, 2016;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 14, 2016

 

/s/ John P. Campi

John P. Campi

Principal Financial Officer

 

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of SQL Technologies Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Campi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1)       the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)       the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ John P. Campi

John P. Campi

Chief Executive Officer

and Principal Executive Officer

 

November 14, 2016

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of SQL Technologies Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Campi, principal financial officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1)       the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)       the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ John P. Campi

John P. Campi

Principal Financial Officer

 

November 14, 2016

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.